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ABSTRACT 
 
MAUREEN COONEY:  In utero environmental exposures and reproductive endpoints 
(Under the direction of Anna Maria Siega-Riz) 
 
 The etiology of age at menarche, infertility, and endometriosis, three common 
reproductive outcomes is largely unknown.  Environmental chemicals exhibiting endocrine 
disrupting behavior have recently been implicated in a number of reproductive disorders, 
however little research has been done to examine the potential effects of these chemicals on 
adult reproductive health when the woman is exposed in utero.  This research focuses on the 
effects of exposure to cigarette smoke and diethylstilbesterol (DES) experienced in utero and 
three reproductive outcomes:  age at menarche, infertility, and endometriosis.   
 Using data from over 5,000 women enrolled in the National Cooperative DES and 
Adenosis Study (DESAD) and a subsequent follow-up we were able to ascertain in utero 
exposures from the mother and subsequent health outcomes from the daughters later in life.  
Overall, we found no suggestion for a delay or advance in age at menarche for women who 
were exposed in utero to tobacco smoke.  Furthermore, we found null results for the 
associations between in utero tobacco smoke and self-reported infertility and endometriosis.  
This is in contrast to a few earlier studies which have found effects.  We determined that 
women exposed in utero to DES had a 70% increase in the odds for developing 
endometriosis compared to women who were unexposed after controlling for age.  We also 
used these data to determine whether self-reported age at menarche later in life is a reliable 
measure.  Women were asked around the age of puberty to report their age at menarche, and
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 they were queried on this same information approximately twenty years later.  We found that 
self-report of age at menarche later in life is not reliable when exact age at menarche is 
required, but the reliability is good within a year of the first reported age at menarche.  The 
only covariates slightly associated with discordant responses were young age (<30 years) at 
the time of the follow-up survey and originally reported late age at menarche (>14 years).  
These three papers add to a small body of literature and address critical data gaps regarding 
the potential effects of the intrauterine environment on later reproductive health.  These 
findings stress the importance of limiting potentially harmful exposures to pregnant women, 
as health effects may not only be seen at birth, but also years into adulthood.  Furthermore 
our finding with respect to DES highlights the possibility that other endocrine disrupting 
chemicals, both pharmaceutical and those found in our environment may have similar 
adverse reproductive effects.   
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CHAPTER I 
INTRODUCTION 
 
Overview 
Age at menarche, infertility, and endometriosis are reproductive outcomes which 
affect millions of women and can cause physiological, psychological, and financial burden 
for women in this country and worldwide.  Early age at menarche is known to be associated 
with eating disorders, early initiation of sexual intercourse, higher sexually transmitted 
disease and teenage pregnancy rates (Deardorff et al. 2005;Stice et al. 2001).  Infertility 
affects approximately 10-20% of couples trying to conceive and can cause psychological as 
well as financial problems (Redshaw et al. 2007;Cousineau and Domar 2007).  
Endometriosis is a disease which can cause severe pelvic pain, infertility, and can account for 
many days of lost work due to debilitating symptoms (Missmer and Cramer 2003;Eskenazi 
and Warner 1997).     
The etiology of these three outcomes is as yet unknown and while genetics play a 
role, evidence is beginning to accumulate that indicates there may be an environmental 
influence on these outcomes as well.  Endocrine disrupting chemicals (EDCs) are 
anthropogenic compounds that block or mimic the action of endogenous hormones.  There is 
a long list of chemicals that are considered EDCs; however, this proposal will concentrate on 
only two of these many:  Diethystilbesterol (DES) and cigarette smoke.  DES is a synthetic 
non-steroidal estrogen that was synthesized in 1938 and was prescribed to millions of  
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pregnant women over the course of three decades (1938-1971) with the mistaken belief it 
would prevent miscarriage and even enhance pregnancies by lengthening gestation and 
increasing birth weight.  Cigarette smoke contains a mixture of over 4,000 chemicals 
including several which are considered to be EDCs (specifically those belonging to the 
polycyclic aromatic hydrocarbon family). Adult exposure to cigarette smoke is perhaps one 
of the most well studied environmental toxins, but the literature regarding in utero exposure 
to cigarette smoke is sparse.   
This study uses data collected from women (both mothers and daughters) 
participating in two studies: National Cooperative Diethylstilbesterol and Adenosis Study 
(DESAD) cohort and the National Cancer Institute (NCI) DES Follow-up Study.  Currently 
there is a dearth of knowledge regarding the intergenerational effects of environmental 
exposures and reproductive endpoints.  This study will contribute to a sparse and sometimes 
absent literature regarding the in utero effects of these chemicals on reproductive outcomes.  
Furthermore, it will improve upon previous studies’ exposure assessments because the 
exposure is captured across generations by mothers and daughters.  This differs from the few 
previously published studies that use proxy exposure information (daughters reported their 
mothers’ habits while they were pregnant).             
Specific Aims 
The dissertation has four specific aims which are contained in three manuscripts.  The 
first aim is contained in paper one, the second, third, and fourth aims are addressed in paper 
two, and the fifth aim is contained in paper three. 
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Aim 1.  To determine the reliability of self-reported age at menarche later in life using 
measures taken at puberty and approximately 20 years later. 
Aim 2.  To assess the association between in utero exposure to cigarette smoke and 
age at menarche among women not exposed to DES. 
Aim 3.  To examine the association between in utero exposure to cigarette smoke and 
infertility among women not exposed to DES and explore any interaction between 
this association and adult cigarette smoke exposure. 
Aim 4.  To examine the association between in utero exposure to cigarette smoke and 
endometriosis among women not exposed to DES and explore any possible 
interaction with adult cigarette smoke exposure.   
Aim 5.  To determine the association between in utero exposure to DES and 
endometriosis and explore any interactions with in utero cigarette smoke exposure 
and adult cigarette smoke exposure.  
 
Background and Significance 
The intrauterine environment may play an important role in determining future 
reproductive health for women.  There is an evolving body of literature that suggests 
environmental exposures experienced in utero may result in higher risk status for adult onset 
diseases.  This type of research is referred to as the early origins of disease hypothesis 
(Barker 1992).  The time spent in utero may represent a critical window of exposure during 
which environmental insults may permanently and irreversibly alter germ cells and the 
development of the reproductive system in women.    
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Age at menarche is the age in years when a girl experiences the onset of her first 
menstrual period.  Age at menarche is thought to be important not only as a sentinel event but 
also as a risk factor for adult disease and possibly as a marker of increased exposure to 
environmental agents.   
A secular decline in the age at onset of puberty has been reported for some but not all 
developed countries (Castellino et al. 2005;Lindgren 1996;Parent et al. 2003).  A recent 
paper reviewed age at menarche data from National Health and Nutrition Examination Study 
(NHANES) from 1988-1994 and compared this to data collected by NHANES in 1999-2002 
(Anderson and Must 2005).  The authors found that the average age at menarche decreased 
from 12.53 (95% Confidence Interval (CI) = 12.43, 12.63) years in 1988-1994 as compared 
to 12.34 (95%CI = 12.24, 12.45) in 1999-2002.  These differences were even more 
pronounced when the results were stratified by race.   Mexican American girls showed the 
greatest change in average age at menarche during this time with a difference of .15 years 
younger in 1999-2002 as compared to 1988-1994.  Whether this difference can be attributed 
to exposures such as DES and cigarette smoke is speculative since DES exposure during this 
time period was rare and pregnancy smoking rates were highest in Non-Hispanic white 
women (Mathews 1998).    
Earlier onset of puberty has been associated with earlier initiation of intercourse, 
substance abuse, higher incidence of sexually transmitted diseases, and teen pregnancy 
(Deardorff et al. 2005).  Numerous psychological issues have also been attributed to girls 
experiencing an early age at menarche.   A recent study indicated both depression and eating 
disorders were more prevalent among girls who had an earlier age at menarche compared to 
their peers (Stice et al. 2001).  
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Early age at menarche has also been linked to outcomes later in life including 
cardiovascular disease risk and reproductive outcomes including cancers.  A recent study 
found that girls with an earlier age at menarche had an increased risk for cardiovascular 
disease later in life due to deleterious changes in adulthood including changes in insulin, 
glucose, and blood pressure (Remsberg et al. 2005).  Two studies also found that early age at 
menarche conferred a higher risk for spontaneous abortions and poor fertility outcomes later 
in life (Martin et al. 1983;Sandler et al. 1984).  Early age at menarche has also been 
associated with reproductive cancers.   In particular, girls with an early onset of menses are at 
higher risk for breast and endometrial cancers (MacMahon et al. 1982;McPherson et al. 
1996).  It is unclear whether age at menarche itself is the impetus for this increased risk due 
to exposure to more menstrual cycles across the lifespan or if there is some shared effect 
earlier in development that programs the girl for both early age at menarche and high cancer 
risk in her adulthood. 
The consequences of early age at menarche are critical for the reasons outlined above.  
Despite the importance of this commonly collected variable both as an endpoint and a risk 
factor for other outcomes, the reliability of age at menarche has not been well studied in 
populations.  In lieu of a biomarker for puberty, self-reported age at menarche is widely used 
in many epidemiologic studies.  It will be important to determine whether this measure is 
accurate. 
Recent estimates from the 2002 National Survey of Family Growth (NSFG) show that 
12% (7.3 million) women in the U.S. aged 15-44 experience impaired fecundity, while 15% 
of married women suffer from impaired fecundity (Martinez GM et al. 2006).  The definition 
of impaired fecundity in this study included women who reported that a) it was physically 
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impossible for them or their partner to have a baby for any other reason than a sterilizing 
operation b) it was physically difficult or dangerous to carry a baby to term c) they had been 
continuously cohabitating or married, had not used contraception, and had not had a 
pregnancy for three years or longer.  In 2002, 7.4% of married women were infertile (infertile 
was defined in this survey as not having used contraception and also not becoming pregnant 
within 12 months).  Impaired fecundity and infertility as so defined are the cause of 
enormous emotional and financial burden for the couple trying to become pregnant 
(Cousineau and Domar 2007;Farley Ordovensky and Webb 2007).   
The secular pattern of fertility has declined.  This has made it difficult to compare 
fecundity and fertility across populations and investigators have found that rates differ across 
countries (Juul et al. 1999).  The decline in fertility is in part due to pregnancy intentions and 
the desire and ability to limit family size.  Research has called for the monitoring of 
fecundity on a population level as changes in fertility may be a sentinel of environmental 
exposures (Joffe 2003;Olsen and Rachootin 2003), however others have disputed this 
proposal (Sallmen et al. 2005).  
Endometriosis is a complex disease that occurs when endometrial tissue grows 
outside of the uterus where it is normally found.  This ectopic tissue responds to hormonal 
signals, does not grow normally, and can cause severe debilitating pain and infertility.  The 
most accurate way to diagnose endometriosis is by visualization of the pelvis and some argue 
histopathology of explants as well through surgery (a laparoscopy or laporotomy).  Most 
women who present with suspected disease are not taken to surgery right away as alternative 
therapies are available and can ameliorate symptoms of the disease for a large proportion of 
women.  Availability and type of health insurance coverage often dictates treatment options.  
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For example, many women will be treated with hormonal therapies such as birth control or 
other drugs which suppress normal ovulatory function.   
Because the gold standard of diagnosis requires surgery, not all women are 
symptomatic, and the severity of symptoms does not correlate with severity of disease, it is 
very difficult to estimate the prevalence of this disease in the population.  Some women 
present with no symptoms but upon laparoscopy they have very advanced disease, while 
others have many symptoms and minimal or no disease detected with surgery. 
Despite all the challenges in identifying disease in a population, a few estimates of 
the burden of disease on the population level have been offered.  The only population-based 
incidence figure that persists in the literature comes from a study in Olmsted County, 
Minnesota where 8,229 women participated in a cohort study (Leibson et al. 2004).  In this 
study, the incidence of endometriosis was 1.9 per 1,000 person-years.  Prevalence figures 
vary considerably.  In the general population, among women of reproductive age, the 
prevalence of disease has been estimated between 10-15% (Houston 1984;Olive and 
Schwartz 1993).  Among women seeking treatment for pelvic pain, the prevalence of 
endometriosis increases to 20-65% (Strathy et al. 1982;Moen and Muus 1991;Mahmood and 
Templeton 1991;Wardle and Hull 1993;Carter 1994).   
The disease can manifest itself in a number of ways already described.  The most 
common complaint among women with endometriosis is pelvic pain and infertility.  When 
the endometriosis has spread to areas such as the bowel or lung even more serious 
complications may arise resulting in necessary removal of the colon and even death.  A study 
of women in the U.S. Army found the prevalence of disease to be at 6.2% among the forces 
accounting for 21,746 days of missed duty in five years of record review (Boling et al. 1988).  
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Recent studies have linked the presence of endometriosis to autoimmune diseases (Sinaii et 
al. 2002) as well as cancers of the breast and endometrium (Brinton et al. 1997).   
 
Age at menarche 
Genetic causes for early age at menarche have been established as girls whose 
mothers experienced early onset of menses have a higher risk for early onset themselves 
(Graber et al. 1995).  These interesting results should be interpreted carefully as the study 
was conducted in a small sample (75 girls) that was homogenous with respect to race and 
socioeconomic status (SES) which may have influenced the results.   Other factors that 
influence the timing of puberty and the onset of menses have been suggested including 
stressful life events and physical activity level (Goran et al. 1998;Graber et al. 1995).  Both 
physical activity and stress are difficult exposures to measure.  Since these studies were 
published, improvements have been made in refining measurement of physical activity and 
stress which warrant further study of this research question with the improved methodology.    
Perhaps the most commonly cited factor associated with an early age at menarche however is 
obesity.  The declining age of menarche in the U.S. has been attributed to the increasing 
number of overweight and obese children in this country (Baker 1985;Slyper 2006).  One 
theory supporting this evidence is that early menarche is preceded and perhaps influenced by 
pre-pubertal hyperinsulinaemia and insulin resistance.  Accurate measurements of both body 
characteristics as well as age at menarche are critical in assessing this association.  This is 
particularly important because it has also been shown that girls who mature early are heavier 
after the onset of puberty and are often at higher risk for adrenal hyperandrogenism (Ibanez 
et al. 1993).  Finally with respect to EDCs, two studies have shown that girls with higher 
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blood lead levels reach puberty as defined by early age at menarche or attainment of Tanner 
stage 2 pubic hair at later ages than girls with lower blood lead levels (Modern Epidemiology 
1998;Selevan et al. 2003;Wu et al. 2003). 
Less research has focused on the potential effect for prenatal exposures on age at 
menarche; however, the few studies which have addressed this topic indicate that the early 
fetal environment may be important.  An early study found that girls who were exposed in 
utero to alcohol had a later onset of menses than girls who were unexposed (Robe et al. 
1979).  This study relied on the daughter’s self report of their mother’s drinking habits and 
also on retrospectively ascertained age at menarche.   A more recent study examined the 
association between postnatal exposure to polybrominated biphenyls (PBBs) which are EDCs 
and age at menarche (Blanck et al. 2000).  The authors found that girls exposed to higher 
levels of PBBs through breast milk had an earlier onset of menses (11.6 years) than girls who 
were exposed to low levels through breast milk (12.6 years) or those who were not breastfed 
(12.7 years).  This study was limited because there was no actual measure of the chemicals in 
utero.  Instead PBBs transmitted via breast milk were a proxy for this exposure.  This may 
have lead to some exposure misclassification.  While suggestive, this study also relied on 
self-reported age at menarche that was asked up to 15 years after the actual event occurred.  
This presents problems for misclassification of the outcome.  
Animal studies support the hypothesis that exposures experienced in utero affect 
future age at onset of menses (Colborn et al. 1993).  EDCs in particular have been shown to 
be hormonally active and induce changes in age at menarche in various animal species.  A 
study of female alligators exposed to dichlorodiphenyltrichloroethane (DDT) contaminated 
water found large differences in the plasma hormone concentrations and age at which these 
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levels peaked when compared to alligators in the control lake (Guillette, Jr. et al. 1994).  
When rats were exposed to DDT a constant estrus syndrome was produced (Heinrichs et al. 
1971) and rats exposed neonatally to bisphenol A showed an advance in the age at puberty 
(Howdeshell et al. 1999).  Studies in hamsters have also shown the reproductive toxicity of 
cigarette smoke, particularly on the ovary and uterus (Magers et al. 1995).  These studies in 
animals provide evidence that EDCs, including those found in cigarette smoke could have 
human health effects as well, particularly effects related to reproduction and, specifically, the 
age at onset of puberty. 
The timing of onset of menses is under control of the hypothalamic-pituitary-gonadal 
and hypothalamic-pituitary-adrenal systems and, thus, exposures experienced during the 
development of this system may also alter the timing of onset of menses.  The onset and 
progression of puberty itself is actually the final stage of reproductive development and 
maturation (Forest MG 1990).  The synthesis and secretion of lutenizing hormone, follicle 
stimulating hormone, human chorionic gonadotropin, and prolactin by the pituitary are 
initiated during fetal life.  These hormones are critical in the onset of menses.  It has also 
been shown that fetal pituitaries are capable of gonadotropin synthesis and release in vivo 
(Forest MG 1990). 
Smoking’s effect on the endocrine system has been well studied.  It has been 
documented that some of the 4,000 constituents in cigarette smoke are reproductive toxins 
with endocrine reactive properties.  Particularly, cigarette smoke has been investigated for its 
anit-estrogenic activity (Baron et al. 1990;MacMahon et al. 1982;Michnovicz et al. 1986).  
Smoking during pregnancy has also been shown to be associated with changes in the central 
nervous system of children, which further suggests the potential for an in utero effect on 
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onset of menses (Eskenazi and Trupin 1995;Naeye and Peters 1984).  If the hypothalamic 
pituitary gonadal (HPG ) system takes a hit from an environmental exposure early in 
development this may re-program the functions later in life; hence, fetal reprogramming. 
Two previous studies have examined the association between in utero exposure to 
cigarette smoke and age at onset of menses in human populations.  Windham and colleagues 
(Windham et al. 2004) used data from the Child Health and Development Study, a 
longitudinal pregnancy study of families in the San Francisco Bay Area of California who 
were members of the Kaiser Permanente Health Plan.  The women were recruited while 
pregnant during the early 1960s and the children were followed through an adolescent study.  
Data regarding exposure was captured during the prospective pregnancy study using self 
reported smoking habits.  Age at menarche was ascertained from a total of 994 girls from in 
person interviews done at a clinic when the girls were between 16 and 17 years old.      
The authors categorized age at menarche into early (<12 years) and late (>13 years) 
with 12-13 years as the referent group.  The mean age at menarche of the subjects was 12.96 
years with 16% of the girls experiencing onset early and 24% experiencing it late.  More than 
half of the girls were exposed prenatally to cigarette smoke.  An earlier age at menarche was 
observed for those girls experiencing the highest exposures (>20 cigarettes per day) as 
compared to girls whose mothers did not smoke at all during pregnancy.  After adjusting for 
potential confounders the mean age at menarche was a few months (Difference=-.31, 95% CI 
(-.65, 0.03)) earlier among daughters whose mothers smoked a pack or more of cigarettes per 
day compared to girls whose mothers did not smoke.   
The study, however, also had some limitations.  There was a fair amount of missing 
data (200 parents (20%) did not report smoking status) which the authors handled in the 
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analysis by substituting the other parent’s value in for the non-reporting parent.  Exposure 
and outcome misclassification were possible as both were self reported, however, bias is 
unlikely as the exposure was collected before the outcome was assessed.  This was the first 
study to examine the effect of in utero exposure to cigarette smoke and age at menarche.   
 Recently, a second study by the same authors was published (Windham et al. 2008).  
In this study data from the Collaborative Perinatal Project (CPP) and a subsequent follow-up 
study were used to examine the association between in utero exposure to cigarette smoke and 
age at menarche in a different population.  In this study age at menarche was ascertained 
when the daughters were young adults and smoking data was collected from the mother as 
part of the original study which was a prospective pregnancy study.  In contrast to their 
earlier findings, the authors found that exposure to heavy smoking (>20 cigarettes/day) in 
utero was associated with an almost four month delay in onset of menses (OR=0.34 years 
(95%CI (-0.02, 0.66)) compared to women who were not exposed to cigarette smoke in 
utero.  These contradictory findings serve as impetus for our study.       
Age at menarche is used in many studies as both an outcome and a risk factor.  In lieu 
of a convenient and inexpensive biomarker for puberty, most studies rely on self-reported age 
at menarche.  Despite the widespread use of self-reported age at menarche as an indicator of 
age at onset of puberty in epidemiologic studies, the accuracy of recall of this variable has 
not been well studied.  Self reported age at menarche is easy to capture in a questionnaire or 
interview and is often done years after the woman has experienced puberty and kept as part 
of her reproductive history.  Two studies to date have addressed the long term recall of age at 
menarche with sufficient sample size and follow-up of participants.  These studies show 
conflicting results which merit further study on this issue. 
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A retrospective follow-up of participants in the Newton Girls Study (NGS) (Must et 
al. 2002) assessed the accuracy of women’s recall of age at menarche.  The original study 
(1965-1975) was a prospective study of physical growth and sexual maturation which 
included 793 girls in Newton, Massachusetts.  The girls were followed through their first 
menstrual period and for approximately two years afterwards.  In 1998, up to 33 years after 
the original NGS, the participants were re-contacted and asked to recall information about 
their early menstrual characteristics.  Approximately 57% of the original participants agreed 
to participate in the follow-up survey (n=448).  Overall, the authors found that a woman’s 
recall of menarcheal age was good.  Original mean age at menarche was 12.93 (95%CI:  
12.81, 13.06) and recalled mean age at menarche was 12.85 (95%CI:  12.69, 13.00).  On 
average, women recalled their age at menarche as being 0.08 (95%CI: -0.18, 0.01) years 
earlier than their original age.  Recalled and original age at menarche were highly correlated 
(r=0.79, p<0.001).  Fifty five percent of women recalled their age at menarche to within a 
half year of the original age reported.  Seventy-nine percent of women were accurate within 
one year of the original age.    
This study has several strengths.  One of the potential problems in the study, 
however, is that only a little more than half of the original participants also participated in the 
follow-up study.  There is no reason to believe that the lack of participation was related to 
self reported age at menarche.  However, if women who would report a younger or older age 
of menarche did not participate systematically this could be a potential source of bias.  This 
point could have been further explored by characterizing the participating women in relation 
to data from the original study. 
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A recent British study found that the validity of age at menarche when self reported in 
middle age was actually quite poor (Cooper et al. 2006).  This study re-contacted women 
who participated in the original Medical Research Council National Survey of Health and 
Development, initiated in 1946.  Information on age at menarche during an interview 
administered when the girls came in for medical examinations between the ages of 14 and 15.  
A total of 1050 women participated in the follow up study by answering questions on age at 
menarche as part of a mailed survey in 1994.  Of the 946 women with a valid age at 
menarche at both measurement points, 412 (43.6%) had recalled exactly the same age at 
menarche (in years) at age 48.  Overall, 21% of the women had recalled their age at 
menarche as one year older than that recorded in adolescence and 21% remembered their age 
as one year younger than that which was recorded in adolescence.     
This study had a much larger sample size and, thus, power to look at validity and 
predictors of accurate recall, albeit a 41% response rate raising the possibility of non-
differential bias assuming no systematic differences.  The differing conclusions from these 
two studies motivated our reliability study. 
 
Infertility 
Fecundity refers to the biologic capacity of a couple for reproduction while fertility 
denotes demonstrated fecundity as measured with live birth.  While often the two terms are 
used interchangeably incorrectly the two terms have precise meanings.     
Many potential risk factors for subfecundity have been examined in the literature.  
One of the most well studied factors is age and it has been well established that as a woman 
ages her fertility declines.  Women with a high Body Mass Index (BMI) or who are obese are 
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also more likely to experience longer waiting times to pregnancy (Gesink et al. 
2007;Ramlau-Hansen et al. 2007).  Gesink and colleagues examined self reported time to 
pregnancy and BMI within the Collaborative Perinatal Project (CPP) dataset.  The Ramlau-
Hansen paper did a more thorough investigation of BMI and fecundity by taking into 
consideration both male and female BMI during pregnancy in the Danish Birth Cohort.  This 
couple based approach to fertility is ideal when information from a male partner can be 
ascertained.   
Environmental factors have also recently been investigated. Several studies have 
examined the effect of exposure to EDCs during adulthood and time to pregnancy (the 
number of months it takes a couple who is trying to become pregnant), conception delay (a 
time to pregnancy greater than six months), and infertility (a waiting time for pregnancy of 
12 months or greater).  Curtis and colleagues have shown negative effects of pesticides on 
fertility (Curtis et al. 1999;Thonneau et al. 1999) and others have shown similar effects for 
women working in agricultural settings exposed to pesticides (Bretveld et al. 2006).  These 
three studies used self-reported exposure as the measure of pesticide use.  Since the 
collection was retrospective there was the potential for recall bias as well as overall 
misclassification of exposure.  Other authors have shown deleterious effects of cigarette 
smoke (Baird and Wilcox 1985;Hassan and Killick 2004;Munafo et al. 2002;Hughes and 
Brennan 1996;Bolumar et al. 1996;Alderete et al. 1995) on time to pregnancy.  All of these 
studies used self-reported smoking as the exposure.  While this measure is probably more 
accurate and reliable during a time period when cigarette smoking did not carry a social 
stigma (particularly during pregnancy), these studies were all conducted in a modern era 
where some biomarker of exposure such as cotinine levels would be preferable.  Many of 
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these studies also used retrospective report of the exposure which may be subject to recall 
bias if the woman had difficulty conceiving.  Polycholrinated biphenyls (PCBs) have also 
been implicated in research for their negative effects on TTP (Axmon et al. 2000;Buck et al. 
2000;Law et al. 2005) while other authors have found no effect (Axmon et al. 2004;Yu et al. 
2000).  The studies differ in their exposure measurement as some of the authors measured 
PCB concentrations in the serum of the women studied and others used information gathered 
from a questionnaire to designate exposure.  Furthermore, some studies assessing PCB levels 
in serum adjust for lipid values of the woman as these chemicals are lipophilic, whereas other 
studies do not.   
Other lifestyle exposures have been examined as well.  Results are mixed when it 
comes to the effects of self-reported alcohol and caffeine with some studies finding an effect 
while others do not (Juhl et al. 2001;Hassan and Killick 2004;Jensen et al. 1998;Jensen et al. 
1998;Alderete et al. 1995;Zaadstra et al. 1994).     
The anti-estrogenic activity of cigarette smoke has been described (Baron et al. 
1990;MacMahon et al. 1982;Michnovicz et al. 1986) and it is through this activity that 
exposure in utero to the chemicals that make up cigarette smoke may be related to infertility, 
specifically by disturbing early egg genesis and development.   
Ovarian development begins soon after conception (at approximately four weeks 
gestation).  The embryonic germ cells migrate to the primitive gonadal folds (Witschi 1948).  
These primordial germ cells become oogonia dividing by mitosis.  At eight to thirteen weeks 
gestation, the oogonia enter meiosis and then remain in a protracted state of meiotic arrest 
until just prior to ovulation as stimulated by the preovulatory gonadotropin surge (Gondos et 
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al. 1986).  This arrested state lasts for several years until the onset of ovulation which leaves 
the oogonia in a vulnerable state susceptible to environmental toxicants. 
Several animal studies have pointed to the potential for in utero exposure to EDCs 
affecting future fertility.  Decreased adult fertility in mice has been shown following prenatal 
exposure to benzo (a) pyrene which is a component of cigarette smoke (MacKenzie and 
Angevine 1981).  Another finding in mice demonstrates that oocytes were destroyed by 
prenatal exposure to polycyclic aromatic hydrocarbons (Dobson and Felton 1983).  A review 
of the animal literature suggests that compounds in cigarette smoke may interfere with all 
events of reproduction from gametogenesis to early post-implantational development 
(Mattison 1982).  
To date, there have been only three studies which have examined the relation between 
in utero exposure to cigarette smoke and time to pregnancy.  All of these studies used proxy 
exposure information and two found an adverse effect between cigarette smoke exposure in 
utero and adult fecundability (Jensen et al. 1998;Weinberg et al. 1989) while the third study 
found no effect (Baird and Wilcox 1986).   
The first study to address prenatal cigarette smoke exposure and adult fecundability 
was in a population of 600 women in Michigan who were trying to become pregnant (Baird 
and Wilcox 1986).  Women who were pregnant were contacted by telephone and asked to 
report the number of months it took them to become pregnant.  Subsequently, the authors 
sent out a questionnaire to the participants (93% of them responded) querying the couples 
about whether their parents smoked while pregnant with them to assess in utero exposure.   
No evidence was found in this study to support the hypothesis that exposure in utero to 
cigarette smoke caused a decreased time to pregnancy or reduction in fecundability.  The 
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study was well powered, but the exposure information may be suspect as a proxy (the 
daughter) was used instead of the mother or father.  The information on time to pregnancy 
and the exposure were both gathered retrospectively, which may lead to recall bias if the 
pregnancy took a long time to conceive.      
Weinberg and colleagues tried to replicate the earlier findings from Michigan in a 
sample of women from North Carolina who participated in a prospective pregnancy study 
designed to examine the incidence of early losses.  Two hundred twenty-one couples were 
recruited between 1983 and 1985.  At the time of enrollment the women were asked whether 
their mother smoked while she was pregnant with them and also about their household 
exposure before age ten years.  The women were then followed using daily urine collected at 
home, which was later analyzed for the presence of human chorionic gonadotropin.  There 
was a strong negative association between fecundability and prenatal exposure even in the 
unadjusted data.  Their final results (adjusted for age, frequency of intercourse, and the 
woman’s own smoking status) showed that the estimated fecundablity ratio for women 
exposed in utero was 0.7 (95% CI 0.5, 0.9).  This study had a prospective ascertainment of 
time to pregnancy.  However, the measurement of the exposure was retrospectively 
ascertained from the woman as the authors asked women to report their mother’s smoking 
history.  This information on exposure was collected before the outcome so recall bias is not 
a concern, but there could be the possibility for misclassification because of the proxy used 
for information on exposure.  Finally, this study was conducted in a homogenous population 
of highly educated white high SES women limiting the generalizability of the results.      
Finally, Jensen and colleagues prospectively followed 430 Danish couples 
discontinuing contraception who began attempting pregnancy for up to six months (Jensen et 
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al. 1998).  The participants in the study completed surveys regarding lifestyle behaviors in 
the menstrual cycles they were trying to conceive.  The baseline questionnaire also included 
the following question regarding parental exposure to cigarette smoke: “Did your mother 
smoke when she was pregnant with you (Yes or No)?”   The fecundability odds ratio for non-
smoking women who were exposed in utero was 0.70 (95% CI 0.48, 1.03) compared to non-
smoking women who were not exposed in utero.  Women who were exposed in utero and 
smoked themselves had a fecundability odds ratio of 0.53 (95% CI 0.31, 0.91).  The analyses 
were adjusted for BMI, alcohol intake, diseases of the female reproductive organs, semen 
quality, and duration of menstrual cycle.  This study, again, had the benefit of prospectively 
captured exposure and outcome data.  Like the Weinberg study though the authors asked 
daughters to report on their mother’s smoking history while pregnant.  While each of the 
three studies provided interesting information on fecundability none addressed the endpoint 
of infertility. 
 
Endometriosis 
Perhaps, the most commonly cited non-environmental etiology of endometriosis is 
the theory of retrograde menstruation.  This was first described by Sampson in the early 20th 
century (Sampson JA 1927).  The mechanism that underlies this theory is regurgitated 
menstrual effulge through the fallopian tubes which implants and requires 
neovascularization.  However, recently it has been noted that retrograde menstruation is 
common among women of reproductive age (76% of women undergoing laparoscopy during 
menstruation), implicating that this may not be the only factor playing into the development 
of disease (Liu and Hitchcock 1986).   
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The environmental origin of endometriosis has recently been a topic of interest to 
epidemiologists.  There are approximately seven studies to date which present data regarding 
environmental chemicals and risk for endometriosis.  Four studies reported a positive 
association between dioxin (Mayani et al. 1997) or PCBs (Louis et al. 2005;Porpora et al. 
2006;Gerhard and Runnebaum 1992) and endometriosis.  The Mayani study was one of the 
first to use serum concentration levels of the chemicals albeit a small sample size (44 case 
and 35 controls).  Louis and Porpora both assessed serum concentrations of PCBs in relation 
to endometriosis, but only the former studied laparoscopically confirmed disease.  The small 
size of these studies (79 and 80 women respectively) was a limitation in both studies. .   Two 
studies found two- to four-fold increases in risk for endometriosis with dioxin (Eskenazi et 
al. 2002) or PCB exposure (Pauwels et al. 2001) respectively.  Eskenazi and colleagues also 
looked at a population in Seveso, Italy that suffered from an acute accidental chemical 
exposure which may have conferred different levels of risk than that seen in populations 
chronically exposed.  Pauwels and colleagues conducted their study on a small sample size of 
69 infertile, women which may have affected their ability to detect small differences.   
It has been suggested that lifestyle factors may also play a role in risk for 
endometriosis.  Women with lower body mass index (BMI) have recently been shown to be 
at higher risk for the disease when compared to women with larger BMIs (Hediger et al. 
2005).  The authors also found that women who tracked lean throughout their childhood and 
adolescence were at higher risk for the endometriosis suggesting a possible in utero origin for 
the disease.    Through the hypothesized alteration of estrogen levels several studies have 
found smoking and exercise to be protective factors of risk for endometriosis (Cramer et al. 
1986;Cramer and Missmer 2002;Eskenazi et al. 2002;Baron 1996;Matorras et al. 1995) while 
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others have found no such effect (Moen and Schei 1997).  Self-reported smoking during the 
time periods in which it was collected for these studies may be inaccurate leading to the 
potential for exposures misclassification.  Furthermore, exercise was self reported in all these 
studies by using simple questions regarding ever/never exercising.  Even more detailed 
questions regarding how vigorously the exercise was may have improved the exposure 
measurement and helped to distinguish any real effects of the exposure from noise in the 
data.    
Similar to the mechanisms discussed for the previous outcomes, the biologic basis for 
the hypothesis of in utero exposure to EDCs and their subsequent effect on risk for disease 
stems from the ability of these chemicals when present periconceptionally or pre-natally to 
damage vulnerable organ systems which are under development.     
One theory underlying the biologic mechanism by which DES, cigarette smoke, or 
any other EDC might program the body for endometriosis is the possibility that the chemicals 
may cause embryonic müllerianosis rest  (Batt et al. 1990).  In this state, residual pieces of 
the müllerian ducts (an early embryonic structure) proliferate.  It is hypothesized that these 
pieces later become endometrial explants found throughout the body. 
There has only been one study that has explored the association between in utero 
exposure to DES and endometriosis.  Similarly, there is only one study published that has 
examined the association between in utero exposure to cigarette smoke and endometriosis.   
The recent study by Missmer and colleagues is the only one published that has 
examined the association between in utero exposure to DES and endometriosis.  The authors 
used data from the Nurses’ Health Study to examine this question (Missmer et al. 2004).  
During 566,250 woman-years of follow-up 1,226 cases of laparoscopically confirmed 
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endometriosis were reported among women with no past infertility.  Nurses were followed 
with a questionnaire where they reported the presence or absence of endometriosis and the 
method of diagnosis.  Additionally women were asked to recall their mother’s exposure to 
DES while they were pregnant with them.  A validation study was conducted on a subset of 
the women who reported laparoscopically confirmed endometriosis and the reporting was 
accurate 86.6% of the time when the diagnosis was checked against medical records.  The 
authors used a model adjusting for age, calendar time, parity, race, and body mass index at 
age 18.  They observed an 80% greater incidence of endometriosis among women who 
reported being exposed to DES in utero (RR=1.8, 95%CI =1.2, 2.8) compared to unexposed 
women.    
This large study provides initial evidence that women exposed in utero to DES may 
be at higher risk for developing endometriosis later in life.  One of the major flaws of the 
study was the ascertainment of DES exposure.  Women were asked to recall their mother’s 
exposure.  The nurses who participated in this study were asked this during their adulthood 
when their mother may or may not have been living.  Furthermore, this study did not take 
into account the potential effect of smoking and the possible interaction between smoking 
and DES which may also be an important predictor of disease risk.  Finally, the authors 
adjusted for several variables, including parity and BMI which may be on the casual pathway 
between exposure and disease.  We sought to improve upon these limitations in our study of 
the same research question.   
Only one study has examined the association between in utero cigarette smoke and 
endometriosis.  Louis and colleagues found that in utero exposure was associated with a 
lower odds of being diagnosed with endometriosis (Buck Louis et al. 2007).  This study had 
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laparascopically confirmed disease status on women, however, they relied upon proxy 
exposure information (daughter’s were asked to recall their mother’s smoking behavior while 
pregnant).  These authors found the odds for endometriosis were lower among women 
exposed to cigarette smoke in utero (OR=0.22, 95%CI (0.06, 0.82)) who never smoked 
themselves compared to women who were unexposed.   Furthermore, they found the 
association to be even stronger amongst women who were exposed in utero and had smoked 
themselves (OR=0.05 95%CI (0.01, 0.42)) compared to women who were unexposed.  This 
study served as impetus for our work in a different population. 
 
Summary of the literature 
Overall, the data are sparse regarding the research questions.  There are only a few 
published papers that examine in utero exposures and adult reproductive outcomes.  Except 
for two studies examining in utero exposure to cigarette smoke and age at menarche, all 
previous studies use proxies to determine the main exposure measurement.  Our study 
improved upon these exposure measurements with data collected from the mother.  
Therefore, we expect our measurement of exposure is more accurate and reflective of the 
actual in utero exposure.  For DES exposure, physician confirmation was obtained for all 
women classified as exposed and unexposed in our study, which has not been done in 
previous studies looking at in utero DES exposure and endometriosis.   
For age at menarche, two existing studies have examined the association between in 
utero exposure to cigarette smoke and age at onset of menses, for infertility, no studies have 
investigated the effects of in utero exposure to cigarette smoke and infertility, one published 
study has assessed the association between in utero exposure to cigarette smoke and 
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endometriosis, and only one study has been published looking at DES exposure and 
endometriosis.  Because many of these studies have not yet been replicated or tested 
formally, we had a unique opportunity to improve upon previous research methodologies and 
address these gaps in the literature.   
It is hypothesized that women who experience menarche at a later age are also at 
higher risk for endometriosis.  The DESAD dataset offered the possibility of examining a 
continuum of disease by investigating the overlap of outcomes within a woman in the study.  
Specifically, we focused on whether the women who experienced altered age at menarche are 
the same women who developed endometriosis later in life, and ultimately also had problems 
with infertility.  This type of continuum operates under the premise that the woman with all 
of these outcomes may have taken a hit in utero from an environmental chemical that altered 
her reproductive profile throughout the course of her reproductive development.   
The following tables summarize the research to date on environmental factors and the 
three reproductive outcomes discussed in this dissertation:  age at menarche, infertility or 
subfecundity, and endometriosis.  Table 1.1 highlights a sampling of the general 
environmental risk factors that have been studied while Table 1.2 details comprehensively 
the studies which have looked at in utero environmental exposures and the proposed 
outcomes.  
 
Table 1.1  Selected environmental risk factors and various reproductive outcomes 
Author/Date of 
Study 
Exposure Outcome Effect 
Goran et al. 1998 
 
Physical 
activity 
Age at menarche Decreased physical activity 
associated with earlier age 
at menarche 
Graber et al. 1995 Stressful events 
 
Age at menarche No effect 
Baker 1985 Obesity Age at menarche Obesity associated with 
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earlier age at menarche 
Slyper  2006 Obesity Age at menarche Overweight and obesity 
associated with earlier age 
at menarche 
Robe 1976 In utero alcohol Age at menarche Alcohol exposure in utero 
associated with later age at 
menarche 
Blanck et al. 2000 Postnatal PBB 
exposure 
Age at menarche PBB exposure through 
breast milk associated with 
earlier age at menarche 
Gesink et al. 2007 Pre-Pregnancy 
BMI 
TTP Higher BMI associated 
with longer TTPs 
Ramlau-Hansen et 
al. 2007 
Male and 
Female BMI in 
early pregnancy 
TTP Higher BMIs of both 
partners associated with 
longer TTPs 
Curtis et al 1999 Self reported 
pesticide use 
TTP Pesticide use associated 
with longer TTPs 
Thonneau et al. 
1999 
Self reported 
pesticide use 
TTP Pesticide use associated 
with longer TTPs 
Bretveld et al. 2006 Self reported 
agricultural 
pesticide use 
TTP Pesticide use associated 
with longer TTPs 
Baird and Wilcox 
1985 
Self reported 
smoking 
TTP Cigarette smoking 
associated with longer 
TTPs 
Hassan and Killick 
2004 
Self reported 
smoking 
TTP Cigarette smoking 
associated with longer 
TTPs 
Munafo et al. 2002 Self reported 
smoking 
TTP Cigarette smoking 
associated with longer 
TTPs 
Hughes and 
Brennan 1996 
Self reported 
smoking 
TTP Cigarette smoking 
associated with longer 
TTPs 
Bolumar et al. 1996 Self reported 
smoking 
TTP Cigarette smoking 
associated with longer 
TTPs 
Aldrete et al. 1995 Self reported 
smoking 
TTP Cigarette smoking 
associated with longer 
TTPs 
Juhl et al. 2001 Alcohol TTP No effect 
Hassan and Kllick 
2004 
Alcohol and 
Tea 
TTP Alcohol and tea 
consumption associated 
with longer TTPs 
Jensen et al. 1998b Alcohol TTP Alcohol was associated 
with longer TTPs 
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Jensen et al. 1998c. Caffeine TTP Caffeine was associated 
with longer TTPs 
Aldrette et al. 1995 Coffee TTP No effect 
Zaadstra et al. 1994 Alcohol TTP No effect 
Axmon et al. 2000 Fish 
Consumption 
TTP No effect 
Buck et al. 2000 Serum PCB 
levels 
TTP PCB levels associated with 
longer TTP 
Law et al. 2005 Serum PCB 
levels 
TTP PCB levels associated with 
longer TTP 
Axmon et al. 2005 Serum POP 
levels 
TTP POP levels associated with 
longer TTP 
Yu et al. 2000 PCB levels as 
identified from 
accidental 
exposure 
TTP No effect 
Mayani Serum dioxin 
levels 
Endometriosis Dioxin associated with 
endometriosis 
Eskenazi et al. 2002 Serum dioxin 
levels 
Endometriosis Dioxin associated with 
endometriosis 
Louis et al. 2005 Serum PCB 
levels 
Endometriosis PCB levels associated with 
endometriosis 
Popora et al. 2006 Serum PCB 
levels 
Endometriosis PCB levels associated with 
endometriosis 
Gerharad and 
Runnebaum 1992 
Serum PCB 
levels 
Endometriosis PCB levels associated with 
endometriosis 
Pauwels et al. 2001 Serum PCB 
levels 
Endometriosis PCB levels associated with 
endometriosis 
Hediger et al. 2005 BMI Endometriosis Lower BMI associated with 
endometriosis 
Cramer et al. 1986 Smoking and 
exercise 
Endometriosis Smoking and exercise are 
negatively associated with 
endometriosis 
Cramer and 
Missmer 2002 
Smoking and 
exercise 
Endometriosis Smoking and exercise are 
negatively associated with 
endometriosis 
Eskenazi et al. 2002 Smoking and 
exercise 
Endometriosis Smoking and exercise are 
negatively associated with 
endometriosis 
Baron 1996 Cigarette 
Smoking 
Endometriosis Smoking is negatively 
associated with 
endometriosis 
Matorras et al. 1995 Smoking Endometriosis Smoking is negatively 
associated with 
endometriosis 
Moen and Schei Smoking and Endometriosis No effect 
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1997 exercise 
Cramer and 
Missmer 2002 
Caffeine and 
alcohol 
Endometriosis Caffeine and alcohol intake 
are associated with 
endometriosis 
*TTP (time to pregnancy) 
PCB (polychlorinated bi-pheynyls) 
POP (persistent organopollutant) 
 
 
Table 1.2  In utero environmental exposures and reproductive outcomes:  the critical studies. 
Author/Date of 
Study 
Exposure Outcome Effect 
Windham et al. 
2004  
In utero smoke Age at menarche In utero exposure to smoke 
associated with younger age 
at menarche 
Windham et al. 
2008 
In utero smoke Age at menarche In utero exposure to smoke 
is associated with a later 
age at menarche 
Jensent et al 
1998a. 
In utero smoke TTP In utero exposure to smoke 
associated with longer TTPs 
Weinberg et al. 
1989 
In utero smoke TTP In utero exposure to smoke 
associated with longer TTPs 
Baird and Wilcox 
1986 
In utero smoke TTP No effect 
Louis et al. 2007 In utero smoke Endometriosis In utero exposure to smoke 
associated with a reduced 
odds of endometriosis 
Missmer et al. 
2004 
In utero DES Endometriosis In utero exposure to DES 
associated with 
endometriosis 
 
CHAPTER II 
METHODS 
 
Overview 
To evaluate our research hypotheses, we used data from two linked studies which are 
coordinated by the National Cancer Institute (NCI).  The first study initially followed the 
mothers and daughters exposed and not exposed to DES in the early 1970s.  The second 
study was initiated by the NCI as a follow-up study to track the long term health effects of 
DES in these women.  All data were de-identified and are the property of the NCI who gave 
us access for these purposes after approval from the University of North Carolina 
Institutional Review Board.  This was a secondary analysis of already de-identified data and 
an exemption to IRB review was ascertained. 
The study was divided into three separate papers as designated by the five specific 
aims of the dissertation.  The study sample from which the analytic plans were established is 
outlined in detail in the following sections.  The study ultimately assessed the questions of 
whether in utero exposure to cigarette smoke and/or DES were associated with three 
reproductive outcomes:  age at menarche, infertility, and endometriosis and an additional 
methodologic question of whether age at menarche as self-reported later in life is reliable.    
 
Study Sample 
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Numerous studies of women exposed to DES began in the early 1970s, however systematic 
follow up of the women and their offspring ceased in the 1980s due to lack of funding.  In 
1992, the National Cancer Institute (NCI) began a large collaborative study with DES 
researchers at five field centers to reassemble and consolidate cohorts of mothers, daughters, 
and sons who had previously been studied.  Seven thousand four hundred thirty-nine DES 
exposed and unexposed mothers and offspring were included in this study sample. 
The study population that comprises the NCI DES Combined Cohort Follow-Up 
Study is complex.  The NCI DES Combined Cohort Follow-Up Study re-contacted daughters 
from these studies in the nineties to ascertain additional information on health outcomes.   
There are five studies that constitute the NCI DES Combined Cohort Follow-Up Study, 
however for the purposes of this dissertation only the National Cooperative Diethylstilbestrol 
Adenosis (DESAD) study was used. 
The largest cohort of DES exposed and unexposed daughters in the NCI DES 
Combined Cohort Follow-Up study is the DESAD cohort.  The objective of the DESAD 
cohort was to follow daughters exposed in utero to DES yearly with clinical exams to 
monitor for abnormalities of the vagina and cervix.  In 1975, over 4,000 exposed and 1,000 
unexposed daughters were enrolled into the DESAD study at one of five sites across the 
country.  The participating sites included: Baylor College of Medicine, Gundersen Clinic, 
Massachusetts General Hospital, Mayo Clinic, and University of Southern California.  The 
mothers were asked to complete a pregnancy questionnaire at the baseline visit.  The 
daughters completed detailed health history questionnaire and baseline clinical exam at 
enrollment which was completed for most participants by 1978.  The daughters were offered 
free yearly exams until 1983 and then mailed annual questionnaires from 1984-1989. 
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Three types of exposed women were followed during the DESAD study: 1) women 
whose exposure to DES was ascertained by review of prenatal records (47%), 2) women 
referred to the study by outside physicians (32%), and 3) women who "walked-in" to the 
local DESAD clinics seeking free evaluation (21%).  Exposed daughters who were referred 
by outside physicians or who “walked-in” to the clinics were required to have written 
evidence of exposure from prenatal records or a letter from a physician who had provided 
prenatal care during the pregnancy.  Two types of unexposed women were selected: sisters of 
exposed participants (24%) and non-relatives identified from the same record sources as the 
exposed (76%), most of whom were matched to the exposed on year of birth and mother's 
age at delivery.   
Standardized questionnaires were sent to all of the daughters included in the NCI 
DES Follow-up Study.  The questions included: demographic factors, cancer risk factors, 
hormone replacement therapy and use of other hormones, history of sexually-transmitted 
diseases, autoimmune diseases, cancers, infertility and other reproductive problems, and 
major mental illness.  The sex and birthdates of all live-born children were obtained to enable 
possible future study of third-generation offspring.  
Most of the cohorts followed in the past had extensive information available for 
tracing, including social security numbers, last known address, and names and addresses of 
contact persons.  If subjects had moved since the last contact and could not be found through 
listed contact persons, additional methods of tracing were used these included credit bureau 
searches, telephone and alumni directories, town books of addresses, Health Care Financing 
Administration tapes, and a National Death Index Search.  Some subjects had during a 
previous follow-up requested no further contact, and no attempt was made to re-contact 
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them.  
Questionnaire mailings began in January of 1993 and continued through July of 1996 
as subjects were traced.  Seventy-five percent of the questionnaires were completed by April 
1, 1995.  Subjects who did not return the first questionnaire within one month were sent a 
second one, and subsequently, interviewers at each field center attempted to conduct the 
interview by telephone. Study personnel at the field centers inspected the questionnaires for 
completeness and accuracy and telephoned respondents when there were discrepancies or 
large amounts of missing information.      
 
Exposure Measurement  
As previously outlined, in utero exposure to cigarette smoke was the primary 
exposure of interest for several of the aims and a potential effect measure modifier in another 
one of the aims.  The mothers were asked if they smoked during the pregnancy which 
culminated in the birth of the index daughter who was enrolled into the study.  If they 
answered yes, the mothers were then asked to report how many cigarettes they smoked per 
day while pregnant. 
Recent studies discount the value of self-reported smoking habits, particularly during 
pregnancy, as there is a strong stigma attached to this behavior.  However, the dangers of 
smoking during pregnancy were unknown in the late fifties and early sixties when most of 
the mothers in this study were pregnant.  It was not until years later that the Surgeon 
General’s report outlined the consequence of smoking while pregnant and even later (1981) 
when Congress mandated the Surgeon General’s warning be printed on all packages of 
cigarettes.  Furthermore, the reporting of smoking in this era has been found to be highly 
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accurate.  A study of 448 pregnant women during the 1960s who participated in the 
Collaborative Perinatal Project revealed self-reported cigarette smoking was highly 
correlated with cotinine levels measured in stored blood samples obtained during pregnancy 
(Klebanoff et al. 1998).   Based on the assumption that a serum cotinine concentration of >10 
ng/ml represented active smoking, 94.9% of women who denied smoking and 87.0% of 
women who stated that they smoked (kappa=0.83) reported their status accurately.   
Smoking was coded in three ways.  A simple yes/no dichotomous variable was 
created indicating if the mother ever smoked during her pregnancy or never smoked during 
her pregnancy and was coded numerically as one for yes and zero for no.  A second variable 
showed the amount of cigarettes that the mother smoked per day during her pregnancy and 
was examined in a continuous fashion (0-60).  The third variable showed the number of 
packs of cigarettes a woman smoked per day during her pregnancy (≤1 or >1).     
In utero exposure to DES was the primary exposure of interest for aim five.  This study used 
information from the mothers themselves which had been verified against medical records or 
physician report for all women enrolled.  Exposure to DES was a dichotomous variable 
coded as either yes (1) or no (0). 
 
Outcome Measurement 
This study was unique in that the daughters were examined yearly around the time of 
onset of puberty and were asked to report their age at menarche.  Therefore, in terms of 
accuracy, this study should have a close measure of age at menarche.  Furthermore, the 
women were queried about age at menarche approximately 20 years later.  These data were 
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compared to the earlier data to determine the reliability of self-reported age at menarche later 
in life.   
Age at menarche was measured in years and was coded as both a continuous (8-20 
years) variable and as a categorical variable (<12, 12-13, and ≥14).  Early, normal, and late 
were defined according to previously established standard cut-points (Lee 1980).   Fractions 
of years obtained upon analysis were converted to months.      
Information on infertility was collected in the follow-up questionnaire.  Women were 
asked several questions related to infertility, which were used in the analysis.  Specifically, 
they were asked if they had ever tried to become pregnant without success for 12 months or 
more and if they sought treatment for infertility.  A small validation study was conducted on 
a subset of the women reporting infertility.  In this study 63 participants who had reported 
infertility were selected so that all the centers and diagnoses were represented equally.  
Thirty-six women gave permission for review of their medical records.  The treating 
physician was asked to complete a one-page medical record abstract form.  Medical abstracts 
were obtained for 29 of the women.  The reason for infertility reported by 26 of the 29 
participants (90%) in the study was confirmed with medical records (Palmer et al. 2001). 
Infertility was used primarily as a dichotomous variable and coded as yes (1) or no 
(0).  In order to be classified as infertile a woman had to report that she had tried to become 
pregnant for 12 months or more without success and that she had sought medical care for 
infertility.   
Endometriosis was the primary outcome for aims four and five of the dissertation.  In 
this study, the presence of endometriosis was assessed during the NCI follow-up 
questionnaire through the use of several questions.  The questions included were: Have you 
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ever been diagnosed with endometriosis?  If yes, what year were you diagnosed?  How were 
you diagnosed?   
As described earlier, defining endometriosis is difficult on a population level because 
laparoscopy is not always indicated for the symptoms of endometriosis and, in fact, women 
with disease may present with no symptoms at all.  The perfect study of this outcome would 
require all women to undergo laparoscopy so that disease or lack of disease could be 
documented for each woman; however, this is unethical and prohibitively expensive.  This 
study was able to restrict the definition of disease to include only women who were 
diagnosed by laparsocpy, biopsy, hysterectomy, or other gynecologic surgery.  Endometriosis 
was simply used in the analysis as a dichotomous yes (1) /no (0) variable.  
To evaluate the extent that women in this study had more than one of these three 
outcomes a sub-analysis was conducted to determine how many women who had altered 
menarche and also had endometriosis and/or infertility. We modeled the chemical exposures 
in similar logistic regression models taking into consideration that altered menarche and 
endometriosis may be on the casual pathway from exposure to infertility. 
 
Statistical analysis 
Each exposure, outcome and covariate was inspected first using univariate analyses. 
Each continuous variable was assessed to determine the mean, median, mode, standard 
deviation, kurtosis and skewness values.  Continuous variables were examined for 
appropriate cut points for categorizations based on biologic evidence in the bivariate analyses 
and modeling.  Frequencies were assessed for categorical variables.  Missingness was 
addressed and documented in this initial step.  Women who had missing values for the 
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exposure and/our outcome were dropped from the analysis, but missing values on covariate 
data were treated as missing at random.  Descriptive statistics on variables with missing 
values were documented.   
Each variable was assessed in a bivariate manner.  Each covariate including the 
exposure was crossed with the outcome of interest.  Odds Ratios (ORs) and 95% Confidence 
Intervals (CIs) were calculated using a referent group for each of the covariates.  After 
bivariate analyses were run, the presence of potential confounding and effect measure 
modification was reassessed using a Directed Acyclic Graph (DAG)s produced for each aim 
as the a priori information.  
Effect measure modification was assessed formally by stratifying the results in all 
models according to the variables suggested as effect measure modifiers.  A combination of 
statistical testing along with evaluation of the magnitude of difference between the estimates 
when stratified will be used as the approach to determine final effect measure modifiers.  The 
likelihood ratio test for homogeneity was also used as a statistical test of the presence of 
modification (Modern Epidemiology 1998). 
Confounding was based on both information from the DAG (representing a priori 
knowledge in the matter) and an assessment of the change in estimate criteria (ten percent) 
when factors were subtracted from the full model.   
Multivariable models were built based on information from the bivariate analyses.  
Logistic regression models were used and the exposure was classified both as a dichotomous 
variable (yes/no) and when the exposure of interest was in utero exposure to cigarette smoke, 
a continuous measure using the number of cigarettes smoked per day and a categorical 
measure of packs of cigarettes per day during pregnancy were used as well.   We created an 
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indicator variable to distinguish the sisters in the sample from those who were not sister and 
then used Generalized estimating equations (GEE) with logistic regression models (Liang 
and Zeger 1986;Zeger and Liang 1986) to account for the dependency between sisters.       
Aim one was different from the other aims because it did not involve a traditional 
exposure-disease research question.  Instead, aim one was a reliability study.  The univarite 
analyses were conducted in the same manner described above.  Bivariate analyses were 
conducted with the covariates and stratified by whether or not the woman reported the same 
age on both questionnaires or not.  Frequencies were run on the number of women who 
accurately reported their age at menarche in the follow-up questionnaire and these data were 
be analyzed for the amount of disagreement between the two measures if they were not the 
same.  A formal weighted kappa statistic was calculated based on the two measures.  Models 
were built to determine which covariates may influence correct reporting.   
Further details regarding the methods particular to each of the specific aims are 
contained in the following chapters. 
CHAPTER III 
PAPER 1: RELIABILITY OF AGE AT MENARCHE 
 
Introduction 
 
Menarche, defined as the age in years when a young woman experiences the onset of 
her first menstrual period, is an important milestone in a woman’s reproductive life.  It is 
thought to be important not only as a sentinel event, but also as a risk factor for adult disease 
and, possibly, as a marker of increased exposure to lifestyle factors and environmental agents 
both in utero and postnatally.   
Age at menarche is often assessed based on recall many years later.  Many studies, 
particularly those employing the popular life-course approach, rely on the accuracy of this 
variable as reported decades after the initial event took place.  Recalled age at menarche is 
also an integral part of breast cancer risk assessment tools.    Despite the widespread use of 
self-reported age at menarche, the accuracy of recall of this variable has not been well 
studied.   
The National Cancer Institute (NCI) Diethylstilbesterol (DES) Combined Cohort 
Follow-up Study offers a unique opportunity to investigate the reliability of self-reported age 
at menarche from a large dataset with information on age at menarche ascertained at two 
time points:   An initial observation of age at menarche was recorded during the DESAD 
Study, when the participants were teenagers or young adults. The second observation of age 
at menarche was obtained approximately twenty years later.   This study also provides an 
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opportunity to determine factors that may influence the reliability of reporting of age at 
menarche later in life.   This study will provide the data needed to respond to the recent 
conflicting findings (Cooper et al. 2006;Must et al. 2002) on the reliability of age at 
menarche as reported later in life. 
 
Methods 
 
Study Population 
The largest group of DES exposed and unexposed daughters studied in the Combined 
Cohort Follow-Up Study is the DESAD Cohort.  The objective of the DESAD Cohort was 
annual follow up of daughters exposed in utero to DES yearly with clinical exams to detail 
incident abnormalities of the vagina and cervix.  DES use in pregnancy began in 1940 and 
stopped in 1971, with the height of its use in the 1950s.   More than 4,000 exposed and 1,000 
unexposed daughters were enrolled into the DESAD Study at one of five clinical sites across 
the country: Baylor College of Medicine, Gundersen Clinic, Massachusetts General Hospital, 
Mayo Clinic, and University of Southern California.   
At the baseline visit in 1976, mothers of exposed daughters provided information for 
the index pregnancy.  Subsequently, the daughters completed detailed health history 
questionnaires and underwent a baseline clinical exam at enrollment which was completed 
for most participants by 1978.  Correspondingly, the average age at filling out the baseline 
questionnaire in 1976 was 22 (±5), with over two-thirds of the participants between the ages 
of 16 and 25.  The daughters were offered yearly exams until 1983 and mailed self 
administered questionnaires from 1984-1989.  Daughters were asked to report the age (in 
years) they first experienced menstruation or they were referred to a gynecologist if menses 
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was not yet initiated.  These women were asked when menarche began or a year later 
(whichever occurred first). 
Three types of exposed daughters were followed during the DESAD Study: 1) 
daughters whose exposure to DES was ascertained by systematic review of prenatal records 
(47%); 2) daughters referred to the study by outside physicians (32%); and 3) daughters who 
"walked-in" to the local DESAD clinics seeking evaluation (21%).  Exposed daughters 
referred by outside physicians or who were “walk-ins” to the clinics were required to have 
written evidence of exposure from prenatal records or a letter from a physician who had 
provided prenatal care during the pregnancy.  Two types of unexposed women were selected: 
sisters of exposed participants (24%) and non-relatives identified from the same record 
sources as the exposed (76%), most of whom were matched to the exposed on year of birth 
and mother's age at delivery.   
From 1993-1995, women were re-contacted from various studies for a follow-up 
study regarding women’s adult health.  All daughters from the DESAD Cohort were included 
in the NCI DES Follow-up Study if they had documented exposure status (either as exposed 
or unexposed from medical records) and had responded to at least one mailed questionnaire 
between 1984 and 1989.  Standardized questionnaires were sent to the daughters included in 
the National Cancer Institute DES Combined Cohort Follow Up Study.  The questions 
included: demographic factors, use of oral contraceptives, cancer risk factors, hormone 
replacement therapy and other hormones, history of sexually-transmitted diseases, 
autoimmune diseases, cancers, infertility and other reproductive problems, and major mental 
illness.  Women were asked in this follow-up questionnaire to report the age when they 
started their first period.  Women who did not return the first questionnaire within one month 
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were sent a second one, and subsequently, interviewers at each field center attempted to 
conduct the interview by telephone.  
Data analysis 
 
The original reported age at menarche (in years) queried of the initial visit in 1976-
1978 was assumed to be the most accurate report. In both surveys, the question was phrased 
as “How old were you when you had your first menstrual period?”  The participant recorded 
their answer in years on both surveys. 
A weighted Kappa statistic and the Pearson correlation coefficient were used to assess 
concordance for age at menarche.  Additionally, odds ratios and 95% confidence intervals 
were calculated for selected covariates to determine if any demographic characteristics or 
prenatal exposures were associated with concordant responses.    
Additionally, a sensitivity analysis was conducted to assess the magnitude of effect 
change when different definitions of age at menarche were used in a typical exposure-
outcome study where age at menarche was the outcome.  Specifically, we tested the 
association of in utero exposure to smoke and age at menarche using the original report of 
age at menarche as the outcome and then using only the age given at the follow-up to 
examine any differences.  The same analytic techniques were used for both analyses (logistic 
regression). 
 
 
Results 
 
Of the 5,049 women in the DESAD Follow-Up Study 79% (n=3998) had values for 
both reports of age at menarche.  Women who were missing either the original age at 
menarche value or the age from the follow-up were excluded from the analysis. However, 
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these women did not differ statistically from the women included on important covariates 
including education, race, DES exposure status, maternal smoking status, gravidity, or 
attained age when menarche age information was provided (data not shown). 
 
Overall, 55% of the women in the study reported the same age at menarche 
approximately 20 years later, whereas 45% of the women reported a different age (Table 
3.1).  However, the mean values for age at menarche from the two surveys were comparable 
at 12.8 (± ~1.4).  When comparing the distributions of age at menarche from the two surveys, 
no difference in the two reports is observed (Figure 4.1).  When the definition of 
concordance was extended to be within a year on either side of the true value, 90% 
(N=3,614) of the women reported the same age at menarche.  Of those who misreported their 
age, 842 underestimated the age and 938 overestimated the age.  Among women who 
misreported their age by three or more years, women whose first reported age at menarche 
was older than normal (>14 years) tended to under-report their age compared to women 
whose first reported age at menarche was normal or early.  Approximately 80% of the 
women over- or under- reported age by only one year.  The weighted kappa statistic 
reflecting agreement among the original and follow-up reports of exact year of menarche was 
0.62 95%CI (0.60, 0.63) and the Pearson correlation coefficient was 0.71(p<0.05). 
Multiple characteristics including prenatal exposures were examined to assess their 
association with a concordant report later in life.  Of all the characteristics examined, only 
first reported age at menarche and attained age at the follow up survey were meaningfully 
associated with the accuracy of report later in life (Table 3.2).  Notably, DES exposure status 
was not associated with concordance despite the theory that exposed daughters might 
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remember events in their reproductive history more accurately.  Even the time lapse between 
the two surveys did not affect accuracy of recall.  Women who were less than thirty years old 
at the time of the second survey were less likely to accurately report their age at menarche 
than women who were 40-49 years old at the time of the survey (OR=0.7, 95%CI (0.6, 0.9)).  
Finally, women whose first reported age at menarche was late (>14 years) (OR=0.7, 95%CI 
(0.6, 0.8)) were less likely to report accurately later in life compared to women whose age at 
menarche was normal (12-14 years).   
In the sensitivity analysis, we found that when age at menarche was categorized using 
the data collected later in life did alter the effect estimates, however, when age at menarche 
was examined continuously the estimates did not change.  Specifically, it shifted them 
towards the null value.  In the original analysis with the first reported age at menarche the 
odds ratio for the association between in utero smoke exposure and early age at menarche 
was 1.3 (95%Ci 0.8, 1.8) whereas with the age reported at the follow-up survey (OR=1.0, 
95%CI (0.7, 1.5)).  Similarly, using the original report, in utero smoke exposure was 
associated with late age at menarche (OR= 1.1, 95%CI (0.8, 1.5)) and this result was again 
attenuated when the follow-up age at menarche was used (OR=0.9 95%CI (0.6, 1.2)). 
Discussion   
Exact recall of age at menarche was found to be limited with only 55% of the 
participants correctly remembering their age at menarche.  Overall, however, there was no 
difference in the mean age at menarche reported from the two surveys.  
Furthermore, when the definition of accurately reporting was extended to encompass a year 
on either side of the original age at menarche, 90% of women were classified as correctly 
remembering their age at menarche.  It is possible that the narrow age span over which 
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menarche actually occurs might allow for comprehensive coverage by small errors or that the 
mean actual age at menarche may be equal to the mean recalled age and still have 
considerable misclassification if the under and over reporting balance each other out.    
The only covariates that influenced the concordance of the two reports of age at 
menarche were the age of the woman at the follow-up survey and the first reported age at 
menarche (Table 3.2).  Girls who experienced onset of menses late (>14 years) were less 
likely to report the same age at menarche years later as compared with girls who had a 
normal age at menarche (12-14 years) (OR=0.7, 95%CI (0.6, .08)).  When very late 
menarche (>16 years) was examined this association was no longer present.     
The age at the time women filled out the survey also proved to be an interesting factor 
affecting the probability of remembering age at menarche correctly.  One might assume 
women who were younger (≤ 30 years) at the follow-up survey would be more accurate in 
their reporting as they were closer in time to when the event actually occurred; however, we 
found the opposite to be true.  This was not explained by confounding due to the high 
proportion (21%) of women in this group whose age at menarche was on the later side of 
normal >14 years.   
A few reports on the reliability of age at menarche have previously been published.  
Much of the early research was done on historical cohorts with differing intervals between 
actual menarche and recall (Bean et al. 1979;Bergsten-Brucefors 1976;Casey et al. 
1991;Damon and Bajema 1974;LIVSON and McNEILL 1962).  The correlation coefficients 
in these studies ranged from (0.60-0.80) despite the interval of recall being between 1 and 39 
years.  However, two of these studies had limited sample sizes (n=160) and  (n=43),  
respectively (LIVSON and McNEILL 1962;Bean et al. 1979;Bergsten-Brucefors 1976) and 
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one was only able to successfully follow up one third of the surveyed  population(Casey et al. 
1991).   
   Two more recent studies have come to differing conclusions, serving as the impetus 
for this study(Cooper et al. 2006;Must et al. 2002).  A retrospective follow-up of participants 
in the Newton Girls Study (NGS) investigated the reliability of various menarchal 
characteristics (Must et al. 2002).  Girls were recruited in third and fourth grade to participate 
in the study and their mothers completed monthly questionnaires about their daughter’s 
growth, development, and onset of their first menstrual period (in years and months).  In 
1998, approximately 57% of the daughters were re-contacted 33 years later and provided 
recalled menarche in years and months.  Overall, the authors found that a woman’s recall of 
menarchal age reported by her mother was good.  Original mean age at menarche was 12.93 
95% CI (12.81, 13.06) and recalled mean age at menarche was 12.85 95%CI (12.69, 13.00).  
On average, women recalled their age at menarche as being 0.08 95%CI (0.01, 0.18) years 
earlier than their original age.  While our results are similar, our conclusions differ from 
Must and colleagues who find that recall of age at menarche was generally quite good.  The 
Pearson correlation coefficient from this study (r=0.79) is similar to that found in our study 
(r=0.71).  These authors found that women with an earlier age at menarche remembered their 
age better than those whose menarchal age was closer to the mean.  Also, women with older 
ages at menarche (>16 years) remembered better than women with the mean menarchal age.  
We did not make these same observations when we looked at women with older age at 
menarche (>16 years) in our data. Finally, they did not have information on early life 
exposures, birth weight, or adult covariates such as gravidity which could be associated with 
reporting correctly.       
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 In contrast, our conclusions are more similar to Cooper and colleagues (Cooper et 
al. 2006)  who found that at best there was only moderate agreement between the two 
measures of age at menarche.  This study re-contacted women who participated in the 
original Medical Research Council National Survey of Health and Development, that was 
initiated in 1946.  Nine hundred forty-six women (37.1% response) from the original study 
participated and answered questions on age at menarche as part of a mailed survey in 1994. 
While these authors found a slightly lower Pearson correlation coefficient (r=0.66) between 
the two measures compared with ours, they also found that only 43.6%  (compared with our 
45%) of the women queried recalled exactly the same age at menarche and concluded that 
the ‘validity’ of age at menarche when self-reported in middle age was actually quite poor 
(Cooper et al. 2006). Overall, they found 21% of the women had recalled their age at 
menarche as one year older than that recorded in adolescence and 21% remembered their age 
as one year younger than that which was recorded in adolescence. This study was larger than 
Must and colleagues with 946 women participating, but had some weaknesses because 
women who were originally interviewed at age 14-15 years and had not yet experienced 
menses were not followed further to ascertain their age at menarche.  Cooper and colleagues 
also found greater agreement among women with higher education levels, which we did not 
observe. 
 In summary, we found that self-reported age at menarche as reported 20 years 
after it was initially collected is prone to recall errors.  Although there was a great amount of 
misreporting of the exact age at menarche (44%), the degree of misreporting was actually 
quite small, with most women misreporting by only one year.  To the best of our knowledge, 
our study is the largest to date on this issue, and has extensive information on potential 
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covariates.  We are limited by the participation rate in our study, which while higher than 
previous studies still leaves 20% of the women for whom we do not have information.  
However, this should not introduce bias as characteristics of the women who were not 
included are similar to those who were included.  We are also limited because age at 
menarche was measured in whole years and therefore subtle differences may not be seen with 
a unit of measure this large.  It is possible that when women were asked to recall their age at 
menarche that they interpreted the question as asking when they regularly started 
menstruating, which is often times different from the onset of first menses.  Finally, we 
cannot be confident of the accuracy of the daughter’s first report as it was not captured 
prospectively in time.  
 Results from our sensitivity analysis suggest that when age at menarche is 
categorized and examined as an outcome in a study, the effect estimates that are generated 
can be affected by the misclassification of age at menarche as reported later in life.  In our 
example the estimates were shifted towards the null by approximately thirty percent in one 
instance, which would arguably change the conclusions of the analyses. 
 These results translate to a dual conclusion.  If the exact year a girl reaches 
menarche is an integral part of calculations for risk (such as in some calculators and tools for 
estimating cancer risk), then self-reported age at menarche reported later in life may be 
unreliable.  Furthermore, studies which depend on remotely recalled age at menarche to 
categorize the outcome of menarche by early, normal, and late, should also be wary of this 
variable. A year error in either direction may put women into the incorrect category.  For 
instance in our study 596 women originally reported having an early age at menarche (<12 
years), yet at the follow-up survey only 74 percent of these women reported an early age at 
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menarche.  Therefore, 152 women would have been misclassified.  For early age at menarche 
this resulted in a sensitivity of 74% and a specificity of 94%.  If early age at menarche was 
associated with a health outcome and those who misreported did not differ on their outcome 
status, this misclassification would push the effect estimate towards the null.  As age at 
menarche is a risk factor for various diseases, including breast cancer, the impacts of this 
type of misclassification on different outcomes should be explored in detail by researchers in 
such fields.  Finally, for studies examining age at menarche as the outcome, small effects 
(such as those observed in environmental and hormonal exposures) would also be missed or 
distorted with slight misreporting as was observed in our study.  However, for studies 
interested solely in the mean age at menarche, remotely recalled age at menarche is reliable.   
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Table 3.1 Errors in age at menarche for women reporting their age in the follow up survey, 
DESAD study, 1975-1994 (N=3998).  
 
 N % 
Concordant reports 2218 55.5 
Discordant  reports 1780 44.5 
   
     Number of years under-reported   
     1 671 79.7 
     2 135 16.0 
     3 24 2.9 
     4 8 1.0 
     5+ 4 0.5 
Total # under-reporting 842  
   
     Number of years over-reported   
     1 725 77.3 
     2 166 17.7 
     3 31 3.3 
     4 10 1.1 
     5+ 6 0.6 
Total # over-reporting 938  
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Table 3.2  Characteristics of women in DESAD study, 1975-1994 with values for age at 
menarche from both the initial visit and the follow up survey by concordance of age at 
menarche values (N=3998). 
 
 
 
Concordance of Age at Menarche 
 
 
 
 
 
Agree 
(n=2218) 
Disagree  
(n=1780) 
ORa 95%CIb 
 
n % n %   
Highest grade completed       
High School or Less 269 12.1 281 15.8 0.9 (0.8, 1.0) 
Some College 510 23.0 429 24.1 1.0 --- 
Graduated College 1432 64.6 1067 59.9 1.1 (1.0, 1.1) 
Missing 7 0.3 3 0.2   
       
Ethnic background       
White 2185 98.5 1754 98.5 1.1 (0.8, 1.4) 
Non White 28 1.3 26 1.5 1.0 --- 
Missing 5 0 1 0   
       
Ever smoked       
Yes 884 39.9 777 43.7 0.9 (0.9, 1.0) 
No 1332 60.1 1002 56.3 1.0 --- 
Missing 2 0 1 0   
       
Exposed to DES       
Yes 1765 79.6 1409 79.0 1.0 (0.9, 1.1) 
No 453 20.4 371 20.8 1.0 --- 
Missing 0 0 0 0   
 
      
Ever pregnant       
Yes 1725 77.8 1431 80.4 0.9 (0.9, 1.0) 
No 493 22.2 346 19.4 1.0 --- 
Missing 0 0 3 0.1   
       
Age at menarche (as reported from 
original survey) 
      
< 12 336 15.1 260 14.6 1.0 (0.9, 1.1) 
12-14 1744 78.6 1324 74.3 1.0 --- 
> 14 138 6.2 196 11.0 0.7 (0.6, 0.8) 
Mean age (SD)c 12.7 (1.3) 12..9 (1.4)   
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Age at 1994 survey       
≤ 30 42 1.9 57 3.2 0.7 (0.6, 0.9) 
31-39 797 35.9 725 40.7 0.9 (0.9, 1.0) 
40-49 1342 60.5 972 54.6 1.0 --- 
≥ 50 37 1.7 26 1.5 1.0 (0.8, 1.2) 
Mean (SD) 40.6 (4.6) 40.0 (4.8)   
Missing 0 0 0 0   
       
Time lapse between surveys (years)       
≤14  162 7.3 119 6.7 1.0 --- 
15-17  700 31.6 558 31.3 1.0 (0.9, 1.1) 
18-20  1356 61.1 1103 62.0 1.0 (0.9, 1.1) 
       
Low birth weight (grams)       
< 2500 245 11.0 202 11.3 1.0 (0.9, 1.1) 
≥ 2500 1933 87.2 1546 86.9 1.0 --- 
Missing 40 1.8 32 1.8   
Mean (SD) 3139.4 (535.4) 3136.2 (564.7)   
 
      
BMI at age 20 (kg/m2)       
< 18.5 292 13.2 251 14.1 1.0 (0.9, 1.0) 
18.5-24.9 1666 75.1 1317 74.0 1.0 --- 
25-29.9 136 6.1 124 7.0 0.9 (0.8, 1.1) 
30+ 34 1.5 29 1.6 1.0 (0.8, 1.2) 
Missing 90 4.1 59 3.3   
Mean (SD) 20.9 (3.0) 21.0 (3.1)   
 
      
BMI at 1994  (kg/m2)       
< 18.5 82 3.7 72 4.0 1.0 (0.8, 1.1) 
18.5-24.9 1399 63.1 1140 64.0 1.0 --- 
25-29.9 439 19.8 322 18.1 1.0 (1.0, 1.1) 
30+ 253 11.4 209 11.7 1.0 (0.9, 1.1) 
Missing 45 2.0 37 2.1   
Mean (SD) 24.1 5.0 24.1 5.1   
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Mom’s age at birth       
< 20 43 1.9 37 2.1 1.0 (0.8, 1.2) 
20-24 428 19.3 360 20.2 1.0 (0.9, 1.1) 
25-29 789 35.6 630 35.4 1.0 --- 
30-34 582 26.2 438 24.6 1.0 (0.9, 1.1) 
35-40 247 11.1 181 10.2 1.0 (0.9, 1.1) 
≥ 40 55 2.5 42 2.4 1.0 (0.9, 1.2) 
Missing 74 3.3 92 5.2   
Mean (SD) 29.2 (5.1) 29.0 (5.1)   
       
Mom smoked in pregnancy       
Yes 741 33.4 651 36.6 0.9 (0.9, 1.0) 
No 1363 61.5 1027 57.7 1.0 --- 
Missing 114 5.1 102 5.7   
       
Packs per day (among smoking moms)       
≤ 1 319 43.0 275 42.2 1.0 --- 
> 1 386 52.1 343 52.7 1.0 (0.9, 1.1) 
Missing 36 4.9 33 5.1   
 
a
 Crude Odds Ratio  
b 95% Confidence Interval 
c
 Standard Deviation  
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Figure 3.1  Frequency of age at menarche as reported from original study and follow up 
survey. 
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CHAPTER IV 
PAPER 2:  IN UTERO EXPOSURE TO CIGARETTE SMOKE AND 
REPRODUCTIVE OUTCOMES 
 
 
 
Introduction 
 
Age at menarche, infertility, and endometriosis are three important reproductive 
outcomes impacting millions of women and each can be associated with substantial physical, 
psychological, and financial burden for affected individuals.  The epidemiology of altered 
age at menarche, infertility, and endometriosis is largely unknown.  A common origin has 
been hypothesized, but as yet, the ordering of events is imprecise.  For example is early or 
late onset puberty in the pathway to endometriosis and/or infertility?  An evolving body of 
evidence indicates the intrauterine environment may play a role in the development of these 
and other female reproductive outcomes (Buck Louis et al. 2007;Missmer et al. 2004;Baird 
and Newbold 2005;Hatch et al. 2006;Palmer et al. 2001;Windham et al. 2004;Colbert et al. 
2008;Baird and Wilcox 1986;Jensen et al. 1998;Weinberg et al. 1989;Windham et al. 2008).  
A recent review of endocrine disrupting chemicals and their effects on female reproductive 
disorders highlights the importance for more research focusing on the intrauterine 
environment as a potential risk factor (Crain et al. 2008).   
In utero exposure to cigarette smoke has been reported to be associated with adverse 
female fecundity.  Exposure in utero to cigarette smoke was associated with a 3 month earlier
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age at menarche in a study by Windham and colleagues done in California (Windham et al. 
2004), and a 3.7 month delay in another recent study by the authors (Windham et al. 2008).  
Similarly, early work by Baird et al. found no association between in utero  cigarette smoke 
exposure and fecundability (Baird and Wilcox 1986).  However, subsequent authors later 
reported that women exposed in utero required a longer time-to-pregnancy in comparison to 
unexposed women (Weinberg et al. 1989;Jensen et al. 1998). Only one study to date has 
examined in utero exposure to cigarette smoke and endometriosis.  Louis and colleagues 
found that in utero exposure was associated with a lower odds of being diagnosed with 
endometriosis (Buck Louis et al. 2007).  
Mechanisms underlying these observations are not fully understood despite 
recognition that cigarette smoke contains 4,000 constituents purportedly to be reproductive 
toxins with endocrine reactive properties (Baron et al. 1990;MacMahon et al. 
1982;Michnovicz et al. 1986).  Studies examining the effect of in utero exposure to cigarette 
smoke on reproductive outcomes are sparse; however, animal evidence suggests a plausible 
biologic mechanism for such an association.  The timing and onset of menses are under 
control of the hypothalamic-pituitary-gonadal (HPG) and the hypothalamic-pituitary-adrenal 
(HPA) axes.  Exposures experienced during the development of this system which occurs in 
utero may be important for the activation of other mechanisms directing the onset of puberty 
later in life.  A recent review of environmental chemicals and their effect on timing of 
puberty stresses the possibility that these exposures could occur early on in utero not 
manifesting their effects until puberty or even later (Buck Louis et al. 2008).  Studies on 
alligators, hamsters, and rats exposed to various endocrine disrupting chemicals such as 
dichlorodiphenyltrichloroethane (DDT), bisphenol A (BPA), and tobacco smoke have shown 
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a range of effects from differences in age of peak plasma hormone concentrations, an 
advance in the age of puberty, and effects on the ovary and uterus, respectively (Guillette, Jr. 
et al. 1994;Heinrichs et al. 1971;Howdeshell et al. 1999;Magers et al. 1995).  Several animal 
studies have also shown the deleterious effects of cigarette smoke on mouse fecundity.  
Decreased adult fertility in mice has been shown after in utero exposure to benzo (a) pyrne, a 
constituent of tobacco smoke (MacKenzie and Angevine 1981).  Another finding 
demonstrates that oocytes were destroyed after prenatal exposure to polycyclic aromatic 
hydrocarbons (Dobson and Felton 1983).  Finally, endometriosis is widely known as an 
estrogen-dependent disease.  The reduced odds ratios for endometriosis among smokers that 
have been observed (Cramer et al. 1986;Missmer and Cramer 2003) may be due to a 
hypoestrogenic state that can be induced in some women by smoking and/or the interference 
of nicotine and cotinine (important components of cigarette smoke) with steroid synthesis 
converting androgens into estrogens (Barbieri et al. 1986).  Also, in utero cigarette smoke 
may affect müllerianosis, the ability of embryonic tissue from the Müllerian Duct to 
proliferate, which leads some to hypothesize that endometriosis is essentially a disease that 
develops in utero and which is  activated later in life when hormonal stimuli are present (Batt 
et al. 1990).        
We sought to examine the association between in utero cigarette smoke and three 
reproductive outcomes - age at menarche, infertility and endometriosis - in a large cohort of 
women with intensive medical follow-up to examine the consistency of effects across 
outcomes and a possible shared in utero origin.    
 
Methods 
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Study Population 
We used data from the National Cooperative Diethylstilbesterol Adenosis (DESAD) 
study which followed daughters exposed and unexposed in utero to Diethylstilbestrol (DES) 
yearly with clinical exams to monitor for abnormalities of the vagina and cervix.  In 1975, 
over 4,000 exposed and 1,000 unexposed daughters were enrolled into the DESAD study at 
one of five sites across the country.  The participating sites included: Baylor College of 
Medicine, Gundersen Clinic, Massachusetts General Hospital, Mayo Clinic, and University 
of Southern California.  In 1994, the National Cancer Institute (NCI) sent mailed 
questionnaires to the original participants querying them on subsequent health exposures and 
outcomes.   
Only women who were not exposed to DES (n=1034) were chosen for this analysis to 
assess the specific effects of in utero cigarette smoke and the three fecundity outcomes in the 
absence of a known reproductive and developmental toxicant, i.e., DES.  Information on 
menarche, infertility and endometriosis accompanied with in utero exposure to cigarette 
smoke was available for 950 (92%), 764 (74%), and 738 (71%) of the eligible women, 
respectively.     
In the age at menarche analysis, there were 745 women who had no sisters, 86 
women who had one sister in the study, and 11 women who had two sisters in the study.  For 
the infertility analysis, 610 women had no sisters in the study, 68 had one sister and six had 
two sisters.  Finally, for the endometriosis analysis 590 women had no sisters in the study, 65 
had one sister and six women had two sisters in the study.  
Mothers completed a pregnancy questionnaire, and daughters completed a detailed 
health history questionnaire followed by a clinical examination in the mid-1970s.  Daughters 
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were followed with annual physical examinations through 1984 and then mailed self 
administered questionnaires from 1985 through 1989.  A follow-up questionnaire querying 
the daughters about subsequent health outcomes and potential exposures was initiated by the 
NCI in January of 1993 and continued through July of 1996.  Eighty one percent of daughters 
from the eligible unexposed to DES cohort completed this 1994 questionnaire. 
Data Analysis 
Information on in utero exposure to cigarette smoke was ascertained at the baseline 
questionnaire from the mother when she brought her daughter in for the first DESAD visit.  
Mothers were asked about cigarette smoking (yes/no) during the index pregnancy.  If women 
reported smoking, they were asked to specify how many cigarettes they smoked per day 
while pregnant. 
Daughters’ age at menarche was ascertained from the baseline questionnaire which 
asked daughters to report their age (in whole years) when menstruation first occurred.   Age 
was categorized into the widely accepted categories of early (≤ 11 years), average (12-13 
years), and late (≥ 14 years) (Lee 1980).   Infertility and endometriosis were self reported on 
the 1994 follow-up questionnaire.  We assessed infertility with three separate definitions.  
The strictest definition we applied was when a woman was considered infertile only if she 
answered yes to both of the following questions:   
Have you ever tried to become pregnant for 12 months or more without success? 
(yes/no) 
Have you ever been seen by a physician for difficulty getting pregnant?  (yes/no) 
 
We relaxed this definition to answering yes to either of the above criteria and also to just 
answering yes to the question of trying for more than 12 months to account for the many 
women who may have difficulty conceiving but who do not seek care (Chandra A et al. 
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2005).  Women were classified as having endometriosis if they reported ever having been 
diagnosed by any one of the following methods:  laparoscopy, biopsy, hysterectomy, or any 
other gynecologic surgery. 
All covariates were examined using frequencies (for categorical variables) and means 
(for continuous variables) by the three outcomes.  Odds ratios (ORs) and 95% confidence 
intervals (CIs) were calculated for each covariate.  Unconditional logistic regression was 
used to examine the association between in utero cigarette smoke exposure and the 
dichotomous outcomes: early age at menarche, late age at menarche, infertility, and 
endometriosis.  Age at menarche was also examined in a continuous fashion to look for any 
subtle differences between groups.  Each outcome was examined individually and also 
simultaneously with the other outcomes to account for the possibility that the exposure 
affected multiple outcomes on the same biologic pathway. Generalized estimating equations 
(GEE) were utilized to account for the dependency between observations of sisters included 
in the study (Zeger and Liang 1986;Liang and Zeger 1986).     
Potential confounders were initially determined a priori based on an association with 
both in utero exposure to cigarette smoke and the outcome.  In all three models where 
outcomes were considered individually education was considered a potential confounder (as 
a surrogate for socio-economic status).  Daughter’s race was a potential confounder in the 
age at menarche analysis.  History of sexually transmitted diseases and daughter’s smoking 
status were considered as potential confounders in the models for the outcomes of 
endometriosis and infertility.  Finally, infertility was considered as a potential confounder in 
the model with the outcome of endometriosis.  In the model considering any of the outcomes 
combined, only education was included as a potential confounder due to the possibility that 
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many of these covariates and outcomes could be on the pathway between exposures and 
disease.  If inclusion of the confounders did not change the effect estimate >10%, the 
covariate was excluded from the final model.   
We stratified the in utero exposure to cigarette smoke-outcome relationship by the 
daughter’s smoking status as this was considered a potential effect modifier for all of the 
outcomes except for age at menarche (we did not have data on the daughter’s smoking habits 
before she attained menarche).  Additionally, a cutoff value of p<.10 for a pseudo likelihood 
ratio test was used for the interaction term in all models to confirm effect modification.   All 
analyses were done using SAS® statistical software program version 9.2 (SAS Institute 
2006). 
 
Results 
Of the 950 women in the age at menarche analysis, approximately 37 percent were 
exposed in utero to cigarette smoke.  One hundred twenty-two women were classified as 
having an early age at menarche, 572 had an average age at menarche, and 256 had a late age 
at menarche.  Age at menarche was not associated meaningfully with any of the covariates 
except for body mass index (BMI).  Women with lower BMI had an increased odds for late 
age at menarche compared to women with a normal BMI (Table 4.1).  The odds for having 
either an early or a late age at menarche were slightly increased (OR=1.3, 95%CI (0.8, 1.8)) 
and (OR=1.1, 95%CI (0.8, 1.5)), respectively, among women who were exposed in utero to 
cigarette smoke compared to unexposed women.  However, these associations disappeared 
when packs/day and cigarettes/day were assessed (Table 4.2).  Education and the daughter’s 
race did not change the effect estimates more than 10%, and the unadjusted models were 
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appropriate for this outcome (Table 4.2).  No association was observed for age at menarche 
when it was considered as a continuous variable (mean change in age= -0.07, 95%CI (-0.14, 
0.01)).     
Overall, 93 women were classified as infertile in this analysis according to the 
strictest definition requiring physician diagnosis.  Forty-five of the women were exposed in 
utero to cigarette smoke irrespective of infertility status (Table 4.3).  None of the other 
covariates examined were associated with infertility except for education.  Women who 
graduated from college had an elevated odds for infertility compared to women with only 
some college education (OR=1.7, 95%CI (1.0, 2.9)).   This association, however, may be 
more of a function of care seeking behavior rather than infertility.   Regardless of what 
definition of infertility was used, estimates of the odds for infertility comparing women who 
were exposed in utero to cigarette smoke compared to women who were unexposed hovered 
around one (Table 4.4).  These null results persisted when cigarettes/day and packs/day were 
examined, and when results were stratified by the daughter’s smoking status as an adult.  
Adjustment for sexually transmitted diseases (STDs) and education as a surrogate for 
socioeconomic status did not change the estimates and, thus, unadjusted models are 
presented.   
Of the 738 women in the endometriosis analysis, 58 (8%) women were classified as 
having disease according to our definition (Table 4.5).  The only covariate associated with 
endometriosis risk was ever having been pregnant, which showed a reduced risk (OR=0.4, 
95%CI (0.2, 0.6)).  Logistic regression analyses showed a decreased odds of endometriosis 
for women exposed in utero to cigarette smoke (OR=0.7, 95%CI (0.4, 1.2)), even when 
results were stratified by whether the daughter smoked and when packs/day or cigarettes/day 
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were examined (Table 4.6).  STDs, education, and infertility were included in the initial 
models as potential confounders, but did not change the estimates and, therefore, were not 
included in the final model.  
All three outcomes were simultaneously assessed to address the shared etiology and 
the possibility that a woman might have multiple outcomes.  The hypothesized pathway is 
that exposure in utero to cigarette smoke would be associated with an altered age at 
menarche followed by infertility and endometriosis.  Only four women in our study had all 
three outcomes, while 16 had both infertility and endometriosis, 18 had late menarche and 
infertility, 15 had late menarche and endometriosis, 15 had early menarche and infertility, 
and 11 women had early menarche and endometriosis.  These sample sizes were too small to 
produce stable estimates. When the combined outcomes were examined in the full cohort of 
DES exposed and non-exposed daughters, the result for the effect of in utero cigarette smoke 
exposure on all combinations of the outcomes was esentially null after adjusting for 
appropriate confounders (data not shown). 
 
Discussion 
 
Overall, we found no evidence to suggest that in utero exposure to cigarette smoke 
was associated with age at menarche or infertility, however there was a decreased odds for 
endometriosis among women exposed in utero to cigarette smoke compared to unexposed 
women participating in the DESAD study.  The findings for age at menarche and infertility 
are in contrast to the few previous studies published in this area (Baird and Wilcox 
1986;Buck Louis et al. 2007;Jensen et al. 1998;Weinberg et al. 1989;Windham et al. 
2004;Windham et al. 2008), but those for endometriosis are in the same direction as the one 
previous study on this topic (Buck Louis et al. 2007).   
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Two previous studies have examined the association between in utero cigarette 
smoke exposure and age at menarche (Windham et al. 2004;Windham et al. 2008).  In her 
first study, Windham and her colleagues used data from the Child Health and Development 
Study, a longitudinal pregnancy study of families in the San Francisco Bay Area of 
California who were members of the Kaiser Permanente Health Plan to examine whether 
exposure in utero to cigarette smoke affected age at menarche.  Maternal smoking during 
pregnancy was assessed upon enrollment into the study and daughters were asked to recall 
their age at menarche in adolescence in years and months.  The mean age at menarche was a 
few months earlier among daughters whose mothers smoked a pack or more of cigarettes per 
day compared to girls whose mothers did not smoke(-.31, 95% CI (0.65, 0.03)).  The authors 
also found that the odds of late menarche were slightly reduced when comparing mothers 
who smoked heavily (OR=0.69, 95%CI (0.38, 1.23)) to mothers who did not smoke at all.  In 
our study, we found no difference between the mean age of menarche for women exposed 
and unexposed in utero to cigarette smoke (mean=12.9 in each group).  However, our study 
is limited by only having data on menarche recorded in years, whereas the Windham study 
had years and months for 55% of the girls.  Additionally, Windham and colleagues had 
information on environmental tobacco smoke exposure in childhood which could have 
affected their results.  These data were not available in our study.  In a second study using 
data from two cohorts which were followed after participating in the Collaborative Perinatal 
Project in the 1960s, Windham and colleagues actually found results contradicting her earlier 
work.   Girls born to mothers who were heavy smokers (20+ cigarettes/day) during 
pregnancy had a delay of 0.31 years (95%CI (0.008, 0.61)) when compared to girls born to 
mothers who were not smokers.  This translates to an almost four month delay in age at 
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menarche.  This second study had smoking measured across the pregnancy and, thus, the 
categorization of the exposure may be better than previous studies.  However, the authors had 
to rely on recalled age at menarche (in whole years) later in life (around reproductive age) for 
the outcome.  Again, in our study we did not find such a strong association between in utero 
exposures and age at menarche.  We assessed menarche as a continuous variable and found 
the mean difference in age at menarche for daughters whose mothers smoked during 
pregnancy versus daughters who were not exposed in utero was -.07 (95%CI (-0.2, 0.1)).  
This difference is much smaller than that seen in previous studies by Windham and her 
colleagues.    
To date, there have been only three studies which have examined the association 
between in utero exposure to cigarette smoke and time to pregnancy (TTP) a measure of 
fecundability.  All of these studies used proxy exposure information, and two found an 
adverse effect between cigarette smoke exposure in utero and adult fecundability (Weinberg 
et al. 1989;Jensen et al. 1998), while the third study found no effect (Baird and Wilcox 
1986).  There are no published studies to our knowledge that look at the outcome of 
infertility, per se, with respect to in utero cigarette smoke exposure.  We restricted our 
definition of infertility by first including only women who reported that they had experienced 
a waiting time of more than 12 months before becoming pregnant and who saw a physician 
for difficulty becoming pregnant.  This is in keeping with a previous work examining the 
effect of DES on infertility in the same population (Palmer et al. 2001).  However, it is 
possible that infertility was not accurately captured in our study as choices about family size 
and care seeking behaviors of women may have led to misclassification of a woman’s 
infertility status.  We also examined less stringent criteria for infertility to account for 
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possible misclassification of disease status and our results did not change.     A small 
validation study of specific infertility diagnoses showed that women in this cohort can 
accurately report their infertility diagnosis (90% of the diagnoses were confirmed) (Palmer et 
al. 2001).  However, only 50% of those women queried agreed to have their records 
searched.  There is no reason to believe that any misclassification would have been 
differential on the exposure, as mothers and daughters were queried separately on respective 
exposure/outcome information.    
We are only aware of one paper assessing the relation between in utero exposure to 
cigarette smoke and endometriosis (Buck Louis et al. 2007).  This study of a laparoscopic 
cohort found a reduced odds ratio for endometriosis among women who were exposed in 
utero to cigarette smoke (OR=0.2, 95%CI (0.1, 0.8)) compared to unexposed women.  Our 
study found a similar effect for endometriosis.  Two important differences in these studies 
may have accounted for our estimate’s lack of statistical significance.  First, the Louis et al. 
study used proxy exposure information, as they relied on daughters reporting of maternal 
smoking status while pregnant while our study queried the mothers.  Secondly, we relied on 
self-reported endometriosis in the DESAD cohort, while the Louis et al. study had 
laparoscopically-confirmed disease status.  Self-reported endometriosis diagnosis can be 
unreliable, since disease manifestation is varied in different individuals.  Previous studies 
have found that endometriosis based on symptoms or medical history has low concordance 
with laparoscopic diagnosis (Duleba 1997;Eskenazi et al. 2001).   Therefore, we sought to 
improve this diagnosis by restricting the definition to women who had confirmed 
endometriosis by either laparoscopy, biopsy, hysterectomy, or other gynecologic surgery.  
Despite this effort, it is possible that cases of endometriosis in the population were missed, 
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particularly those cases which may not have presented with symptoms that may have led to 
the procedures listed above.  In our study eight percent of the sample was diagnosed with 
endometriosis, perhaps somewhat lower than expected.  To our knowledge, one population 
based estimate on incidence for endometriosis has been reported.  Overall incidence of 
diagnosed endometriosis was 1.9 per 1,000 person years in a population of 8,229 women 15 
years and older in Minnesota (Leibson et al. 2004).  Prevalence figures on endometriosis 
depend on the study sample and range from 10-15% in the general reproductive aged 
population (Houston 1984;Olive and Schwartz 1993).       
In conclusion, given the lack of published epidemiologic studies on the effects of in 
utero cigarette smoke and reproductive outcomes.  The follow-up of DESAD allowed for 
initial assessment of the reproductive toxicity of in utero exposure to cigarette smoke and 
three outcomes among women undergoing intensive follow-up and medical evaluation. 
Furthermore, this cohort has information on maternal exposure, which sets it apart from the 
prior studies relying on proxy response by offspring.  The data on exposure were collected in 
an era free from the stigma currently attached to women who smoke cigarettes during 
pregnancy.  Therefore, our exposure data are likely to result in non-differential bias, if any.   
Despite the strengths and size of this study, we had to rely on self-reported outcomes, which 
for infertility and endometriosis can present misclassification problems.  However, it is 
unlikely that any misclassification would be differential as the exposure information was 
ascertained from the mother, and occurred long before any of the reported outcomes.
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Table 4.1  Characteristics of women by early, average, and late age at menarche, DESAD study, 1975-1994, (n=950)a 
 
 
Early 
≤ 11 years 
(n=122) 
Average 
12-13 years 
(n=572) 
Late 
≥ 14 years  
(n=256) 
 
n % ORb 95%CI n % n % ORb 95%CI 
Highest grade completed           
High School or Less 13 10.7 0.9 (0.5, 1.7) 91 15.9 44 17.2 1.1 (0.8, 1.5) 
Some College 19 15.6 1.0 --- 117 20.5 50 19.5 1.0 --- 
Graduated College 66 54.1 1.4 (0.9, 2.3) 260 45.5 121 47.3 1.1 (0.8, 1.4) 
Missing 24 19.7   104 18.2 41 16.0   
           
Ethnic background           
White 120 98.4 1.1 (0.3, 3.8) 562 98.3 256 100 --- --- 
Non White 2 1.6 1.0 --- 9 1.6 0 0 1.0 --- 
Missing 0 0   1 0.2 0 0   
           
Mom smoked in pregnancy           
Yes 50 41.0 1.2 (0.9, 1.8) 198 34.6 97 37.9 1.1 (0.9, 1.4) 
No 72 59.0 1.0 --- 374 65.4 159 62.1 1.0 --- 
Missing 0 0   0 0 0 0   
 
          
Packs per day in pregnancy 
(among smoking mothers) 
          
≤  1 28 56.0 1.0 --- 80 40.4 40 41.2 1.0 --- 
>1 19 38.0 0.6 (0.3, 1.0) 109 55.1 50 51.5 0.9 (0.7, 1.3) 
Missing 3 6.0   9 4.5 7 7.2   
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BMI at age 20 (kg/m2)           
< 18.5 8 6.6 0.8 (0.4, 1.5) 51 8.9 38 14.8 1.4 (1.1, 1.8) 
18.5-24.9 76 62.3 1.0 --- 360 62.9 159 62.1 1.0 --- 
25-29.9 7 5.7 1.1 (0.6, 2.2) 29 5.1 14 5.5 1.1 (0.7, 1.7) 
30+ 2 1.6 1.0 (0.3, 3.7) 9 1.6 0 0 --- --- 
Missing 29 23.8   123 21.5 45 17.6   
Mean (SD) 21.4 (2.8)   21.1 (3.1) 20.5 (2.3)   
 
 
          
Low birth weight (grams)           
< 2500 4 3.3 0.8 (0.3, 2.0) 25 4.4 5 2.0 0.5 (0.2, 1.2) 
≥  2500 118 96.7 1.0 --- 544 95.1 251 98.0 1.0 --- 
Missing 0 0   3 1.0 0 0   
Mean (SD) 3252.8 (470.7)   3332.9 (478.5) 3341.2 (423.6)   
 
          
Mother’s age at birth           
< 20 2 1.6 0.4 (0.1, 1.6) 24 4.2 5 2.0 0.6 (0.3, 1.3) 
20-24 26 21.3 1.0 (0.6, 1.5) 117 20.5 49 19.1 1.0 (0.7, 1.3) 
25-29 49 40.2 1.0 --- 217 37.9 95 37.1 1.0 --- 
30-34 32 26.2 1.0 (0.7, 1.5) 141 24.7 69 27.0 1.1 (0.8, 1.4) 
35-40 11 9.0 0.9 (0.5, 1.5) 59 10.3 23 9.0 0.9 (0.6, 1.4) 
≥  40 2 1.6 0.8 (0.2, 2.9) 12 2.1 11 4.3 1.6 (1.0, 2.5) 
Missing 0 0   2 0.3 4 1.6   
Mean (SD) 28.7 (5.1)   28.7 (5.2) 29.2 (5.2)   
Abbreviations: OR, Odds Ratio CI, confidence interval SD, standard deviation 
a Analysis restricted to women not exposed to DES with information on age at menarche and in utero cigarette smoke exposure  
b
 Odds Ratios comparing early or late age at menarche to average age at menarche  
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Table 4.2 Regression results examining in utero cigarette smoke exposure and age at 
menarche in the DESAD study, 1975-1994 ab.  
 
Abbreviations: OR, odds ratio CI, confidence interval  
a Analysis restricted to women not exposed to DES with information on age at menarche and 
in utero cigarette smoke exposure  
b
 Generalized estimating equations used to estimate mean changes and odds ratios in 
respective models 
 Age at menarche 
(continuous) 
Early age at  
menarche 
Late age at 
menarche 
 Mean 
change 
95%CI OR 95%CI OR 95%CI 
       
Yes/No -0.07 (-0.14, 0.01) 1.3 (0.8, 1.8) 1.1 (0.8, 1.5) 
Cigarettes/Day 0 --- 1.0 (0.9, 1.0) 1.0 (0.9, 1.0) 
Packs/Day -0.02 (-0.07, 0.03) 1.0 (0.8, 1.3) 1.1 (0.9, 1.3) 
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Table 4.3  Characteristics of women in DESAD study by infertility status, 1975-1994 
(n=764) a 
 
 
Infertility Reported 
(n=93) 
No Infertility 
Reported 
(n=671) 
OR 95%CI 
 
n % n %   
Highest grade completed       
High School or Less 15 16.1 129 19.2 1.2 0.6, 2.4 
Some College 15 16.1 163 24.3 1.0 --- 
Graduated College 63 67.7 377 56.2 1.7 1.0, 2.9 
Missing 0 0 2 0.3   
       
Ethnic background       
White 92 99.0 663 98.8 1.1 0.2, 7.0 
Non-White 1 0.1 8 1.2 1.0 --- 
Missing 0 0 0 0   
       
Ever smoked       
Yes 39 41.9 307 45.8 0.9 0.6, 1.3 
No 54 58.1 364 54.3 1.0 --- 
Missing 0 0 0 0   
       
Mom smoked in pregnancy       
Yes 28 30.1 255 38.0 0.7 0.5, 1.1 
No 65 69.9 416 62.0 1.0 --- 
Missing 0 0 0 0   
       
Packs per day in pregnancy 
(among smoking mothers) 
      
≤  1 14 50.0 111 43.5 1.0 --- 
>1 14 50.0 130 51.0 0.9 (0.4, 1.7) 
Missing 0 0 14 5.5   
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BMI at age 20 (kg/m2)       
< 18.5 11 11.8 83 12.4 0.9 0.5, 1.7 
18.5-24.9 72 77.4 508 75.7 1.0 --- 
25-29.9 6 6.5 44 6.6 1.0 0.4, 2.1 
30+ 1 1.1 9 1.3 0.8 0.1, 5.2 
Missing 3 3.2 27 4.0   
Mean (SD) 20.8 (3.0) 21.0 (3.1)   
 
      
BMI at 1994  (kg/m2)       
< 18.5 2 2.2 30 4.5 0.5 0.1, 2.1 
18.5-24.9 55 59.1 413 61.6 1.0 --- 
25-29.9 18 19.4 141 21.0 1.0 0.6, 1.6 
30+ 15 16.1 69 10.3 1.5 0.9, 2.6 
Missing 3 3.2 18 0   
Mean (SD) 24.2 (5.1) 24.1 (5.0)   
 
      
Low birth weight (grams)       
< 2500 1 1.1 26 3.9 0.3 (0.1, 2.1) 
≥ 2500 91 97.9 644 96.0 1.0 --- 
Missing 1 1.1 1 0.1   
Mean (SD) 3132.3 (542.9) 3151.3 (556.7)   
 
      
Age at menarche        
≤ 11 15 16.1 81 12.1 1.2 0.7, 2.0 
12-13 60 64.5 398 59.3 1.0 --- 
≥ 14 18 19.4 192 28.6 0.7 0.4, 1.1 
Missing 0 0 0 0   
Mean age (SD) 12.6 (1.4) 12.9 (1.4)   
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Mother’s age at birth       
< 20 0 0 26 3.7 --- --- 
20-24 24 25.8 130 19.4 1.1 0.7, 1.8 
25-29 41 44.1 250 37.3 1.0 --- 
30-34 16 17.2 182 27.1 0.6 0.3, 1.0 
35-40 9 9.7 66 0.1 0.9 0.4, 1.7 
≥ 40 3 3.2 11 1.6 1.5 0.5, 4.3 
Missing 8 8.6 32 4.8   
Mean (SD) 28.8 (5.0) 29.2 (5.2)   
Abbreviations: OR, odds ratio CI, confidence interval SD, standard deviation 
a Analysis restricted to women not exposed to DES with information on infertility (reported 
more than 12 months trying to become pregnant without success and saw a physician for 
difficulty getting pregnant) and in utero cigarette smoke exposure  
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Table 4.4  Regression results examining in utero cigarette smoke exposure and reported infertility in the DESAD study, stratified by 
woman’s smoking status 1975-1994 ab.  
 
 Tried to get 
pregnant >12 
months and sought 
care for infertility 
Either tried to get 
pregnant >12 months 
or sought care for 
infertility 
Tried to get 
pregnant >12 
months 
 OR 95%CI OR 95%CI OR 95%CI 
       
Yes/No 0.7 (0.4, 1.1) 0.9 (0.6, 1.3) 0.8 (0.5, 1.2) 
Cigarettes/Day 1.0 (0.9, 1.0) 1.0 (0.9, 1.0) 1.0 (0.9, 1.0) 
Packs/Day 0.8 (0.6, 1.1) 0.9 (0.7, 1.2) 0.9 (0.7, 1.1) 
Among daughters who smoked       
Yes/No 0.7 (0.4, 1.4) 0.8 (0.4, 1.4) 0.7 (0.4, 1.4) 
Cigarettes/Day 1.0 (0.9, 1.0) 1.0 (1.0, 1.1) 1.0 (0.9, 1.0) 
Packs/Day 0.8 (0.5, 1.1) 0.9 (0.6, 1.2) 0.8 (0.6, 1.2) 
Among daughters who did not smoke       
Yes/No 0.7 (0.4, 1.3) 0.9 (0.6, 1.6) 0.7 (0.4, 1.3) 
Cigarettes/Day 1.0 (0.9, 1.1) 1.0 (0.9, 1.0) 1.0 (0.9, 1.0) 
Packs/Day 0.9 (0.6, 1.3) 1.0 (0.7, 1.4) 0.9 (0.6, 1.3) 
       
Abbreviations: OR, odds ratio CI, confidence interval  
a Analysis restricted to women not exposed to DES with information on infertility and in utero cigarette smoke exposure  
b
 Generalized estimating equations used to estimate odds ratios
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Table 4.5  Characteristics of women in DESAD study, by endometriosis diagnosis 1975-1994 
(n=738)a 
 
 
Endometriosis 
(n=58) 
No Endometriosis 
(n=680) 
OR 95%CI 
 
n % n %   
Highest grade completed        
High School or Less 8 13.8 124 18.2 0.9 (0.4, 2.3) 
Some College 11 19.0 160 23.5 1.0 --- 
Graduated College 38 65.5 379 55.7 1.4 (0.7, 2.7) 
Missing 1 1.7 17 2.5   
       
Ethnic background       
White 57 98.3 673 99.0 0.6 (0.1, 4.0) 
Non-White 1 1.7 7 1.0 1.0 --- 
Missing 0 0 0 0   
       
Ever pregnant       
Yes 38 65.5 578 85.0 0.4 (0.2, 0.6) 
No 20 34.5 100 14.7 1.0 --- 
Missing 0 0 2 0.3   
     
Ever smoked       
Yes 21 36.2 309 45.4 0.7 (0.4, 1.1) 
No 37 63.8 362 53.2 1.0 --- 
Missing 0 0 9 1.3   
       
Mom smoked in pregnancy       
Yes 17 29.3 253 37.2 0.7 (0.4, 1.2) 
No 41 70.7 427 62.8 1.0 --- 
Missing 0 0 0 0   
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Packs per day in pregnancy 
(among smoking mothers) 
      
≤  1 9 52.9 113 44.7 1.0 --- 
>1 7 10.4 128 50.6 0.7 (0.3, 1.8) 
Missing 1 1.5 12 4.7   
       
BMI at age 20 (kg/m2)       
< 18.5 11 19.0 74 10.9 1.7 (0.9, 3.2) 
18.5-24.9 41 70.7 510 75.0 1.0 --- 
25-29.9 4 6.9 43 6.3 1.1 (0.4, 3.1) 
30+ 0 0 10 1.5 --- --- 
Missing 2 3.4 43 6.3   
Mean (SD) 20.5 (2.9) 21.0 (2.9)   
 
      
BMI at 1994  (kg/m2)       
< 18.5 3 5.2 26 3.8 1.4 (0.4, 4.2) 
18.5-24.9 34 58.6 414 60.9 1.0 --- 
25-29.9 14 24.1 138 20.3 1.2 (0.7, 2.2) 
30+ 5 8.6 71 10.4 0.9 (0.4, 2.1) 
Missing 2 3.4 31 4.6   
Mean (SD) 23.7 (4.2) 24.1 (5.0)   
 
      
Low birth weight (grams)       
< 2500 2 3.4 23 3.4 1.0 (0.3, 3.9) 
≥  2500 56 96.6 656 96.5 1.0 --- 
Missing 0 0 1 0.1   
Mean (SD) 3311.1 (461.6) 3309.9 (463.8)   
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Age at menarche        
≤ 11 11 19.0 88 12.9 1.5 (0.8, 2.9) 
12-13 32 55.2 404 59.4 1.0 --- 
≥ 14 15 25.9 188 27.6 1.0 (0.6, 1.8) 
Missing 0 0 0 0   
Mean age (SD) 12.6 (1.4) 12.9 (1.4)   
 
      
Mother’s age at birth       
< 20 2 3.4 20 2.9 1.4 (0.4, 5.8) 
20-24 14 24.1 135 19.9 1.5 (0.8, 2.9) 
25-29 18 31.0 266 39.1 1.0 --- 
30-34 15 25.9 178 26.2 1.2 (0.6, 2.4) 
35-40 6 10.3 64 9.4 1.4 (0.6,3.3) 
≥ 40 2 3.4 12 1.8 2.3 (0.6, 8.8) 
Missing 1 1.7 5 0.7   
Mean (SD) 28.9 (5.7) 28.7 (4.9)   
Abbreviations: OR, odds ratio CI, confidence interval SD, standard deviation 
a Analysis restricted to women not exposed to DES with information on endometriosis (only 
women who had diagnosis by laparoscopy, biopsy, hysterectomy, or other gynecologic 
surgery included) and in utero cigarette smoke exposure  
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Table 4.6  Regression results examining in utero cigarette exposure and endometriosis 
stratified by woman’s smoking status in the DESAD study, 1975-1994 ab. 
 
 OR 95%CI 
   
Yes/No 0.7 (0.4, 1.3) 
Cigarettes/Day 1.0 (0.9, 1.0) 
Packs/Day 0.6 (0.2, 1.7) 
Among daughters who smoked   
Yes/No 0.6 (0.2, 1.6) 
Cigarettes/Day 0.9 (0.8, 1.0) 
Packs/Day 0.5 (0.1, 2.5) 
Among daughters who did not smoke   
Yes/No 0.8 (0.4, 1.6) 
Cigarettes/Day 1.0 (0.9, 1.1) 
Packs/Day 0.9 (0.2, 3.3) 
 Abbreviations: OR, odds ratio CI, confidence interval  
a Analysis restricted to women not exposed to DES with information on endometriosis (only 
women who had diagnosis by laparoscopy, biopsy, hysterectomy, or other gynecologic 
surgery included) and in utero cigarette smoke exposure  
b
 Generalized estimating equations used to estimate odds ratios 
 
 
 
 
CHAPTER V 
PAPER 3:  IN UTERO EXPOSURE TO DES AND ENDOMETRIOSIS 
 
 
Introduction 
Although endometriosis is the third leading cause of gynecologic hospitalization in 
the United States, its etiology is largely unknown (Eskenazi and Warner 1997).  
Endometriosis is a complex disease that occurs when endometrial glands and stroma grow 
outside the uterus and respond to hormonal signals, often growing in an aberrant manner.  
Endometriosis is a difficult disease to study at the population level, given that clinical 
diagnosis requires laparoscopic visualization and its asymptomatic presence in an uncertain 
percentage of fertile women (Leibson et al. 2004).  
Of late, there is considerable speculation that many adult onset diseases originate in utero, 
though little research has focused on gynecologic conditions including endometriosis.  In 
searching the literature, we were able to identify only a few papers focusing on possible 
intrauterine exposures (Buck Louis et al. 2007;Missmer et al. 2004) of which 
diethylstilbestrol (DES) was observed to be associated with increased risk of disease.  
Specifically, an 80% increased risk of endometriosis was observed for self reported DES 
exposure among women participating in the Nurses’ Health Study (NHS) compared to 
unexposed women (Missmer et al. 2004).    DES has been associated with a host of adverse 
health outcomes, including infertility in some (Palmer et al. 2001;Senekjian et al. 
1988;Kaufman et al. 1986;Berger and Alper 1986) but not all studies 
 78
(Barnes et al. 1980;Cousins et al. 1980), and also is reported to be associated with a 50% 
increase in the odds of endometriosis among infertile women seeking diagnostic evaluation 
for infertility (Berger and Alper 1986).   In addition, in utero DES exposure has been 
associated with cervical stenosis which results in a back flow of menstrual blood (Stillman 
and Miller 1984).  This is one of the most commonly accepted etiologies of endometriosis.  
Thus, in utero exposure to a potent estrogenic compound and risk of endometriosis remains 
understudied serving as the impetus for this study.   
    
Methods 
Study Population 
In 1975, over 4,000 exposed and 1,000 unexposed daughters were enrolled into the 
National Cooperative Diethylstilbesterol and Andenosis Study (DESAD) at one of five sites 
across the country:  Baylor College of Medicine, Gundersen Clinic, Massachusetts General 
Hospital, Mayo Clinic, and University of Southern California.  Three types of exposed 
women were followed during the DESAD study: 1) women whose exposure to DES was 
ascertained by review of prenatal records (47%); 2) women referred to the study by outside 
physicians (32%); and 3) women who "walked-in" to the local DESAD clinics seeking 
evaluation (21%).  Exposed daughters who were referred by outside physicians or who 
“walked-in” to the clinics were required to have written evidence of exposure from prenatal 
records or a letter from a physician who had provided prenatal care during the pregnancy.  
Two types of unexposed women were selected:  1) sisters of exposed participants (24%) and 
2) non-relatives identified from the same record sources as the exposed (76%), most of 
whom were matched to the exposed on year of birth and mother's age at delivery.   
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In 1976 mothers were asked to complete a pregnancy questionnaire and daughters 
filled out a detailed health history questionnaire and underwent a baseline clinical exam at 
enrollment.  The daughters were offered yearly exams until 1983 and then mailed annual 
self-administered questionnaires from 1984-1989.  In 1994, the National Cancer Institute 
(NCI) sought to re-contact participants to query them about subsequent health issues, 
including the development of cancers and reproductive outcomes experienced later in life.  
Women were included in our analysis if they responded to the 1994 self-administered 
questionnaire and had complete information on the question for endometriosis diagnosis. 
This included 3876 (77% eligible) women.   
Data Analysis 
Exposure to DES was coded as a dichotomous variable (yes/no) and was confirmed 
for all women in the study at the initial DESAD study visit.  Medical records for some 
women included dose and timing information on DES, and when available these data were 
used.  Gestational age (in completed weeks) at first exposure was categorized based on the 
distribution of data.  Information on birth weight and gestational age were available for 80% 
of the women in the study from obstetrical charts.  The remaining 20% of the data was 
ascertained from the mothers at their daughter’s enrollment into the study.  Body mass index 
(BMI) was calculated as weight in kilograms per height in meters squared and was divided 
into categories of underweight, normal, overweight, and obese based on established cut-
points set by the Centers for Disease Control and Prevention. 
Endometriosis was self-reported at the 1994 questionnaire.  Women were asked if 
they had ever been diagnosed by a physician as having endometriosis (yes/no).  If they 
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answered yes, they were asked how the endometriosis was diagnosed.  Only women who 
reported that their endometriosis was diagnosed by laparoscopy, hysterectomy, biopsy, or 
other gynecologic surgery were included as endometriosis cases. 
All covariates were examined using frequencies (for categorical variables) and means 
(for continuous variables) by endometriosis status.  Odds ratios and 95% confidence intervals 
were calculated for each covariate.  Unconditional logistic regression was used to examine 
the association between in utero DES exposure and endometriosis.  Gestational age (in 
completed weeks) at first exposure was considered in models comparing women who were 
exposed at varying times during pregnancy to women who were unexposed.  Gestational age 
at first exposure, birth weight, and gestational age at birth of the daughter were also 
examined as continuous variables in the logistic models.  Generalized estimating equations 
were utilized to account for the dependency between observations of sisters included in the 
study (Zeger and Liang 1986;Liang and Zeger 1986).  Confounders were determined based 
on an a priori association with both in utero exposure to DES and the outcome.  Education 
(as a surrogate for socio-economic status), history of sexually transmitted diseases, 
daughter’s smoking status (ever/never) and mother’s smoking status during the index 
pregnancy, age, and gravidity were considered as potential confounders.  If inclusion of a 
confounder did not change the effect estimate >10%, it was not included in the final model.  
Effect modification was assessed by stratifying the results.  Reported infertility of the 
daughter, smoking status of the mother while pregnant, and if the daughter ever smoked were 
considered as potential effect modifiers.  Additionally, a cutoff value of p<.10 for the pseudo 
likelihood ratio test was used for the interaction term in the logistic model to confirm effect 
modification.   
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We also examined the potential effect of birth weight, preterm delivery and small- 
for-gestational age (SGA) on risk of endometriosis as these have been hypothesized and 
shown in previous studies to be associated with onset of disease later in life.  SGA was 
defined using the Brenner curves for distinguishing those infants born <10% percentile for 
that time period (Brenner et al. 1976).   Briefly, this entailed using rounded measures for 
gestational age and the birth weight limits to determine the 10th percentile for growth in each 
gestational age category (in completed weeks of gestation) . All analyses were performed 
using SAS statistical software version 9.1 (SAS Institute 2006). 
 
Results 
Data were available for 3,876 (77% eligible) women including 2,943 women who had 
no sisters in the study, 382 women with one sister, 45 women had two sisters, seven women 
with three sisters, and one woman with five sisters in the study.  Overall, 472 women were 
classified as having endometriosis (12%).  The majority of women were white and highly 
educated, consistent with the characteristics of who was given DES during pregnancy.  
Seventy-nine percent of the women had ever been pregnant at the 1994 survey and 41% had 
ever smoked in their lifetime.  Seventy percent of the women were of normal BMI at age 20 
years, while this number decreased to around 60% at the 1994 survey.  Finally, over 80% of 
the women were exposed to DES in this sample (Table 5.1). 
Higher body mass index (BMI) at age 20 was associated with a decreased odds for 
endometriosis (OR=0.6, 95% CI (0.2, 1.5)) as was mother’s smoking status while pregnant 
(OR=0.9, 95%CI = (0.7, 1.1)).  Conversely, DES exposure, the daughter’s birth weight of 
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<2500 grams, and nulligravid status were associated with an increased odds of endometriosis 
in the categorical analyses (Table 5.1).   
In the adjusted models, we accounted for age and gravidity of the daughter and found 
an increased odds for endometriosis among women who were exposed in utero to DES as 
compared to women who were not exposed (OR=1.6, 95%CI (1.2, 2.1)).  When women with 
infertility were looked at separately, the increased odds among those exposed to DES was 
attenuated (OR=1.2, 95%CI (0.7, 2.0)).  The same was true when women without infertility 
diagnoses were examined (Table 5.2).   
Women who were exposed very early in gestation (≤ 7 weeks) had an 80% greater 
odds for endometriosis (OR=1.8, 95%CI (1.3, 2.4)) compared to unexposed women.  Similar 
increases in risk were seen across all other categories of gestational age, including a 90% 
increase in odds of disease among women exposed between 11 and 14 weeks compared to 
unexposed women (Table 5.3).  However, women exposed between 8 and 10 weeks gestation 
did not have an increased risk for disease (OR=1.2, 95% (0.8, 1.6)).  Gestational age was also 
examined in a continuous fashion and only a slight increase in risk was observed (data not 
shown). 
We also examined the potential effect of birth weight and preterm delivery on risk of 
endometriosis, given earlier reports of an association.   We observed no association for low 
birth weight (<2500 grams) and preterm birth (<37 weeks) even after controlling for age, 
gravidity, and DES exposure respectively ((OR=1.0, 95%CI (0.7, 1.3)) and (OR=1.1, 95%CI 
(0.8, 1.5))).  There was a slight increase in the odds for endometriosis (20%) associated with 
LBW status among the fertile population; however, this was not statistically significant 
(Table 5.4).  Preterm delivery also conveyed a slightly higher risk for endometriosis after 
 83
adjustment in the total population and in the fertile population, but not in the infertile 
population (Table 5.4).  Birth weight and gestational age were also examined in a continuous 
fashion and no increase in the odds for disease was seen in either model.  Null results were 
obtained when we examined small-for-gestational-age (SGA) status (Table 5.4). 
None of the interaction terms for the potential effect modifiers were statistically 
significant, but the results were stratified by infertility for comparability with previous 
publications.  Furthermore, none of the potential confounders substantially changed the effect 
estimates except for daughter’s age and gravidity which were retained in the final models. 
 
Discussion 
Overall, we found a 70% increased odds of self-reported endometriosis among 
women exposed in utero to DES compared to unexposed women supporting an earlier 
finding  (Missmer et al. 2004).  However, the effect was attenuated when stratifying or 
removing infertile women from the analysis suggesting women who underwent infertility 
evaluation may have been more likely to receive a diagnosis of endometriosis.  This 
discrepancy could be a result of differing definitions of infertility, which has been shown to 
vary in prevalence by stringency of the definition and when asked lifetime versus current.   
The Nurses’ Health Study was able to distinguish between concurrent infertility and past 
infertility, whereas our study did not have this information and relied on an ever/never 
diagnosis of infertility.    
We limited our definition of endometriosis to only those women reporting physician 
diagnosed infertility by one of several operative approaches including hysterectomy, which 
was not recognized in NHS.  While it may be hypothesized that women exposed to DES 
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would undergo more hysterectomies and gynecologic surgeries than women who were 
unexposed due to other concerns about gynecologic health, and/or their heightened 
awareness about gynecologic health given their exposure status, we found no evidence of this 
for this study cohort.  In fact, unexposed women were slightly more likely to report 
hysterectomies than exposed women (18.8% and 17.2%), respectively.  Our results remained 
unchanged when women diagnosed with hysterectomy (n=33) were removed from the 
analysis (data not shown).   
These data concur with earlier work by Hediger and colleagues which suggests an in 
utero origin to endometriosis resulting from the higher risk for disease among women who 
have tracked lean (measured by BMI) historically and at the time of endometriosis diagnosis 
(Hediger et al. 2005).  We decided not to adjust for adolescent BMI, given that it may in the 
pathway between the exposure and endometriosis.  While not statistically significant, women 
in the leanest categories for BMI (<18.5 kg/m2) at age 20 and again at the follow-up survey 
had a 20 and 30 percent (respectively) increased odds for endometriosis when compared to 
women in the normal range for BMI (18.5-24.9 kg/m2).      
A recent study in a laparoscopic cohort found an decreased risk for endometriosis 
among women whose mothers smoked when they were pregnant (Buck Louis et al. 2007).  
We did not find such an effect in our data; however, this could be due to the difference in the 
way exposure was ascertained in the two studies (proxy report by the daughter versus 
maternal report, respectively).  We also did not see a protective effect for ever smoking, 
which has been seen in a few previous studies (Buck Louis et al. 2007;Cramer et al. 
1986;Cramer and Missmer 2002).    
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In addition to examining overall odds for DES exposure and endometriosis in this 
cohort, we also investigated the potential effects of gestational age in completed weeks at 
DES exposure which was available for 62% of women and dose for 26% of women. Over 
seventy percent of women in both the case group and those without endometriosis were 
missing information on dose of DES which may have led to the lack of effect seen for dose 
on endometriosis risk.  The categorical analysis of gestational age at first exposure showed 
higher risks among women who were exposed at varying gestational ages, however, when 
gestational age was examined in a continuous fashion only a slight increase in odds for 
disease were observed, suggesting the lack of an effect for gestational age at exposure.  
No increase in the odds of endometriosis was observed for women’s birth weight, 
gestational age or SGA status.  The effect for birth weight was not consistent with results 
from NHS where a thirty percent increase in risk for endometriosis was found in women 
whose birth weight was <5.5 pounds as compared to women who were 7-8.4 pounds 
(Missmer et al. 2004).  However, these authors failed to control for DES exposure in their 
models, which may have confounded the LBW-endometriosis association.  The discrepancy 
may also be explained by the difference in methods for ascertaining birth weight (mostly via 
medical records in our study versus self-reported by the daughter in NHS).  The Nurses’ 
Health Study also did not see an increase in risk for women born preterm in their data.  When 
the outcomes of birth weight and gestational age were examined in a continuous fashion, the 
null results persisted (data not shown).   
A strength of this study is its exposure measurement, being the first study to examine 
this question with information on medically verified maternal DES exposure.  However, 
important limitations impact the interpretation of findings most notably, the reliance on self 
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reported endometriosis and other relevant covariates.  Despite this, the direction of recall bias 
is not in the expected direction of a possible exaggerated effect.  Our prevalence is 
comparable or less than that reported for women of reproductive age (12%) suggesting that 
misclassification on disease status is minimal.  We recognize that DES exposed women may 
be more vigilant about preventive screening and, hence, have more gynecologic visits and 
thereby be more likely to be diagnosed with endometriosis.  To address this potential 
detection bias, we assessed the frequency of screening visits for cervical cancer (via PAP 
smear) and breast cancer (via mammography) and observed comparable percentage for 
exposed and unexposed women (10% and 9%, respectively).   
Finally, it is possible given the long lapse in time between in utero exposure to DES 
and diagnosis of endometriosis, potential unknown or unmeasured variables could be 
associated with both the exposure and outcome and residual confounding may have distorted 
our results.  Despite these potential limitations, the findings are from the largest known 
cohort with medically verified documentation on DES exposure and are suggestive of an 
association between DES exposure and diagnosis of endometriosis.  While DES has been 
removed from the market, it is a model of the influence of endocrine disrupting chemicals.  
These results emphasize the need for studies to look at long term reproductive health effects 
of exposure to both pharmaceutical and environmental endocrine disrupting chemicals, 
starting with exposure in the womb.    
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Table 5.1  Characteristics of women in DESAD study by endometriosis diagnosis, 1975-1994 
(N=3876)* 
 
Endometriosis 
(n=472) 
No Endometriosis 
(n=3404) 
Odds Ratio 95%CI 
 
n % n %   
Highest grade completed        
High School or Less 57 12.1 429 12.6 1.0 --- 
Some College 94 19.9 783 23.0 0.9 (0.7, 1.2) 
Graduated College 295 62.5 2019 59.3 1.1  (0.8, 1.4) 
Missing 26 5.5 173 5.1   
       
Ethnic background       
White 467 98.9 3357 98.6 1.2 (0.5, 2.9) 
Non-White 5 1.1 46 1.6 1.0 --- 
Missing 0 0 171 0   
       
Exposed to DES       
Yes 405 85.8 2679 78.7 1.6 (1.2, 2.0) 
No 67 14.2 725 21.3 1.0 --- 
Missing 0 0 0 0   
       
Total dose of DES (grams)        
< 500 17  105  1.0 --- 
500-999 10  66  0.9 (0.5, 2.0) 
1000-1999 15  89  1.1 (0.5, 1.1) 
2000-2999 15  96  1.0 (0.5, 1.8) 
3000-3999 15  55  1.3 (0.7, 2.5) 
≥ 4000 78  462  1.0 (0.6, 1.7) 
Missing 325 76.1 2531 74.4   
Mean (SD) 4966.7 8084.6 3706.3 6543.3   
 
      
Gestational Age at First 
Exposure 
      
≤ 7 weeks 104 22.0 587 17.2 1.6 (1.2, 2.2) 
8-10 weeks 57 12.1 555 16.3 1.0 --- 
11-14 weeks 78 16.5 402 11.8 1.7 (1.3, 2.4) 
≥ 15 weeks 70 14.8 549 16.1 1.2 (0.9, 1.7) 
Missing 233 34.5 1860 38.5   
Mean (SD) 9.6 7.8 9.1 8.4   
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Ever Pregnant       
Yes 337 71.4 2706 79.5 1.0  --- 
No 121 25.6 644 18.9 1.4 (1.2, 1.7) 
Missing 14 3.0 54 1.6   
       
Ever Smoked       
Yes 197 41.7 1402 41.2 1.0  (0.9, 1.2) 
No 262 55.5 1907 56.0 1.0 --- 
Missing 13 2.8 95 2.8   
 
      
Mom Smoked in Pregnancy       
Yes 151 32.0 1205 35.4 0.9 (0.7, 1.1) 
No 287 60.8 2027 59.5 1.0 --- 
Missing 15 3.2 172 5.1   
       
Packs per day (among smoking 
mothers) 
      
≤  1 69 45.7 516 42.8 1.0 --- 
>1 74 41.7 632 52.4 0.9 (0.7, 1.2) 
Missing 18 5.3 57 5.0   
       
BMI at age 20 (kg/m2)       
< 18.5 70 14.8 417 12.3 1.2 (0.9, 1.5) 
18.5-24.9 331 70.1 2429 71.4 1.0 --- 
25-29.9 31 6.6 211 6.2 1.1  (0.8, 1.5) 
30+ 4 0.8 53 1.6 0.6 (0.2, 1.5) 
Missing 36 7.6 294 8.6   
Mean (SD) 20.7 (2.9) 21.0 (3.0)   
 
      
BMI at 1994  (kg/m2)       
< 18.5 21 4.4 113 3.3 1.3 (0.9, 2.0) 
18.5-24.9 281 59.5 2067 60.7 1.0 --- 
25-29.9 90 19.1 623 18.3 1.1 (0.8, 1.3) 
30+ 50 10.6 370 10.9 1.0 (0.8, 1.3) 
Missing 30 6.4 231 6.8   
Mean (SD) 23.9 (4.9) 24.2 (5.0)   
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Table 5.2  Odds Ratios and 95% Confidence Intervals for association between DES and 
endometriosis by infertility status among women in the DESAD cohort, 1975-1994.*  
 Total population Among infertile women Among fertile women 
 OR 95% CI OR 95% CI OR 95% CI 
DES exposed†  1.7 (1.3, 2.2) 1.2 (0.7, 2.0) 1.1 (0.8, 1.6) 
DES exposed†† 1.6 (1.2 2.1) 1.2 (0.7, 2.0) 1.2 (0.8, 1.7) 
 
 
*Only women who had diagnosis by laparoscopy, biopsy, hysterectomy, or other gynecologic 
surgery included. 
 
†Adjusted for age  
†† Adjusted for age and gravidity 
 
 
Table 5.3  Odds Ratios and 95% Confidence Intervals for endometriosis by DES exposure at 
varying gestational ages among women in the DESAD cohort, 1975-1994* 
 OR† 95% CI OR†† 95% CI   
Unexposed 1.0 --- 1.0 ---   
≤ 7 weeks 1.8 (1.3, 2.4) 1.7 (1.3, 2.4)   
8-10 weeks 1.2 (0.8, 1.6) 1.1 (0.8, 1.6)   
11-14 weeks 1.9 (1.4, 2.6) 1.9 (1.4, 2.7)   
≥ 15 weeks 1.4 (1.0, 1.9) 1.3 (1.0, 1.9)   
     
       
 
*Only women who had diagnosis by laparoscopy, biopsy, hysterectomy, or other 
gynecologic surgery included. 
 
†Adjusted for age  
†† Adjusted for age and gravidity 
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Table 5.4  Odds Ratios and 95% Confidence Intervals for endometriosis by various birth 
outcomes among women in the DESAD cohort, 1975-1994 
 Total population Among infertile women Among fertile women 
 OR 95% CI OR 95% CI OR 95% CI 
LBW †† 1.0 (0.7, 1.3) 0.8 (0.5, 1.3) 1.2 (0.7, 1.8) 
Preterm delivey †† 1.1 (0.8, 1.5) 0.9 (0.5, 1.5) 1.4 (0.9, 2.1) 
SGA †† 0.9 (0.6, 1.4) 0.8 (0.4, 1.6) 1.0 (0.5, 1.8) 
 
†† Adjusted for age, gravidity, and DES exposure 
*Only women who had diagnosis by laparoscopy, biopsy, hysterectomy, or other 
gynecologic surgery included  
CHAPTER VI 
CONCLUSIONS 
 
Introduction 
  
 A growing body of evidence suggests the intrauterine environment may play an 
important role in the development of adult onset disease.  Despite the accumulating literature 
regarding reproductive effects of exposure to environmental chemicals, little has been 
published regarding the potential effects of in utero exposure to environmental chemicals on 
human reproductive health.     
We sought to expand upon two previous studies examining in utero cigarette smoke 
exposure and age at menarche (Windham et al. 2004;Windham et al. 2008), three papers 
examining in utero cigarette smoke exposure and fecundability (Baird and Wilcox 
1986;Jensen et al. 1998;Weinberg et al. 1989), one study which found an association between 
in utero cigarette smoke exposure and endometriosis (Buck Louis et al. 2007) and one study 
that found an association between in utero DES exposure and endometriosis (Missmer et al. 
2004).  Many of these studies had not been replicated in different populations and only two 
of them (the age at menarche analyses) did not rely upon proxy exposure information.  
Additionally, we used reported age at menarche collected at two different time periods (one 
around the age at puberty and one twenty years later) to test the reliability of self-reported 
age at menarche later in life.  Two recent studies came to differing conclusions on the
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 accuracy of recall later in life (Cooper et al. 2006;Must et al. 2002) serving as the impetus 
for this methodologic analysis. 
 Overall, we were unable to confirm previous findings of an effect (either a delay or an 
advance) in age at menarche after exposure in utero to cigarette smoke.  We also did not find 
that exposure in utero to cigarette smoke increased the odds of developing infertility or 
decreased the odds for developing endometriosis, as other authors have suggested  (Buck 
Louis et al. 2007;Jensen et al. 1998;Weinberg et al. 1989).  We did however, find that 
exposure in utero to DES was associated with an increase of 70% in the odds for developing 
endometriosis compared to women who were unexposed, similar to the one previous 
published study (Missmer et al. 2004).  Finally, we concluded that self-reported age at 
menarche later in life is not reliable when exact age at menarche in years is required, but 
improves when age within a year is considered, confirming a previous study’s suggestion 
(Cooper et al. 2006).   
 
Strengths and Limitations 
 This study was able to utilize a resource of over 5,000 women enrolled in 1976 and 
followed through the nineties to examine the potential effects of an in utero exposure and 
adult reproductive disease.  The size and time period covered by this study are impressive 
and a strength for all the analyses.  Papers two and three utilized information gathered about 
smoking exposure in utero ascertained from the mother several years after her pregnancy.  
This is an advantage over previous studies which have relied upon the daughters to report 
their mother’s pregnancy smoking habits.  Furthermore, the stigma currently attached to 
smoking during pregnancy was absent during the era when mothers were queried about this 
 93
information, so any reporting bias should be limited.  The exposure measurement for DES 
was also a strength for paper three.  DES exposure was reported by the mother and confirmed 
by medical records for all the participants in the study.  This is in contrast to previous studies 
which rely upon the daughter to report the mother’s exposure status.  Furthermore, 
gestational age at first exposure was available for a considerable proportion of the women in 
the study which allowed us to examine whether timing of exposure played a role in the effect 
of DES on development of endometriosis. 
 There were several limitations in this study, which may have affected our 
conclusions.  Firstly, we had to rely upon self-report for all three outcomes.  Self-reported 
age at menarche is perhaps more widely used than self-reported infertility and endometriosis, 
however, more precise timing of puberty, using markers such as breast development and 
development of pubic hair in addition to age at first menses lend more information about the 
onset of puberty.  Self-reported infertility is problematic because women who do not choose 
to have children, but who may be infertile are not captured by this definition.  We restricted 
our definition further and only included women who sought care for infertility.  This could be 
problematic because access to resources and knowledge and/or timing about when to seek 
care may have excluded some women from this category.  Self-reported endometriosis was a 
limitation in our study because many women may not recognize endometriosis even if it is 
present in their bodies because of the varying degrees and symptoms associated with such a 
complex disease.  While we restricted our definition to only women who had been diagnosed 
with surgery, this still may have excluded asymptomatic women or women who did not seek 
a diagnosis for any associated symptoms.  Despite our reliance on self-reported outcomes, it 
is unlikely that any misclassification would be differential with respect to exposure to in 
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utero cigarette smoke.  We also looked at indicators of detection bias in paper 3 to address 
the possibility that women who were exposed to DES might have been more likely to receive 
a diagnosis of endometriosis.   We were also limited by the lack of ascertainment of 
childhood environmental exposure to cigarette smoke.  This may have played a role in the 
onset of menses or may have interacted with the in utero cigarette smoke to affect any of the 
outcomes, but was not available in this dataset.  Finally, we did not have specific data on 
adult smoking behaviors, beyond whether the woman smoked or not.  Such information 
would have been helpful to tease out any interaction or confounding that may have occurred 
in conjunction with in utero exposure to cigarette smoke. 
 
Public Health Importance 
 While our results from the smoking analyses were largely null, other health 
consequences associated with prenatal exposure to smoke are well known.  While our study 
did not find any effects for age at menarche, previous studies have found both delays and 
advances in age at menarche among women whose mother’s smoked when they were 
pregnant.  While more studies are needed to clarify the potential risks, caution about 
exposure during pregnancy is always prudent.  Our results from the DES analysis stress the 
ability for endocrine disrupting chemicals to cause reproductive health effects much later in 
life.  While DES has been removed from the market these findings highlight the possible 
adverse effects of future pharmaceuticals as well as chemicals found in the environment 
which have similar properties.  Finally, our results with respect to the reliability of self-
reported age at menarche later in life may be un-nerving for practitioners and researchers 
who rely on this recalled marker to calculate risks for such things as breast cancer, where age 
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at menarche is considered to be a risk factor.  When exact recall in years is necessitated it is 
better to collect these data prospectively, or at least, around the time of puberty, as we 
observed that report later in life did not concur with earlier report in 45% of the women 
sampled.         
 
Directions for Future Research        
 Our findings add to a small existing literature on the effects of in utero exposures on 
adult reproductive outcomes.  Further research is needed to clarify other potential exposures 
as well as to consider multiple outcomes which may be on the same biologic pathway.  Our 
sample size in the unexposed to DES population was too small to draw any meaningful 
conclusions from the joint analyses, but future work should consider this possibility.  
Improved measures of exposure could also build upon our work.  Biologic markers of 
exposure in the mothers and daughters would help clarify exposure.  It would be ideal to also 
collect cord blood from daughters to tease out various exposures experienced in utero.  
Future studies should also focus on accurate classification of the outcome.  Clinical 
evaluation of girls as they enter puberty or self-reported breast development and pubic hair 
development with tools such as Tanner staging (Tanner JM 1962) would improve the 
outcome measurement in future studies.  Collection of a measure such as time-to-pregnancy 
would give a more accurate reflection of women who had problems trying to conceive, rather 
than having to rely upon self-reported infertility.  Finally, although expensive and time 
consuming, proper evaluation via laparoscopy of women enrolled in studies of endometriosis 
is critical for identifying disease and could improve our understanding of this disease’s 
etiology.   
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